US20150018911A1 - Apparatus, system, and method for minimized energy in peripheral field stimulation - Google Patents

Apparatus, system, and method for minimized energy in peripheral field stimulation Download PDF

Info

Publication number
US20150018911A1
US20150018911A1 US14/317,948 US201414317948A US2015018911A1 US 20150018911 A1 US20150018911 A1 US 20150018911A1 US 201414317948 A US201414317948 A US 201414317948A US 2015018911 A1 US2015018911 A1 US 2015018911A1
Authority
US
United States
Prior art keywords
flexible conductive
conductive surface
examples
lead
lead body
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/317,948
Inventor
Kerry Bradley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Greatbatch Ltd
Original Assignee
Greatbatch Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greatbatch Ltd filed Critical Greatbatch Ltd
Priority to US14/317,948 priority Critical patent/US20150018911A1/en
Assigned to GREATBATCH LTD. reassignment GREATBATCH LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BRADLEY, KERRY
Publication of US20150018911A1 publication Critical patent/US20150018911A1/en
Assigned to MANUFACTURERS AND TRADERS TRUST COMPANY reassignment MANUFACTURERS AND TRADERS TRUST COMPANY SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ELECTROCHEM SOLUTIONS, INC., GREATBATCH LTD., GREATBATCH, INC., GREATBATCH-GLOBE TOOL, INC., MICRO POWER ELECTRONICS, INC., NEURONEXUS TECHNOLOGIES, INC., PRECIMED INC.
Assigned to MICRO POWER ELECTRONICS, INC., ELECTROCHEM SOLUTIONS, INC., GREATBATCH LTD., GREATBATCH, INC., NEURONEXUS TECHNOLOGIES, INC., GREATBATCH-GLOBE TOOL, INC., PRECIMED INC. reassignment MICRO POWER ELECTRONICS, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT)
Assigned to GREATBATCH, INC., GREATBATCH LTD., GREATBATCH-GLOBE TOOL, INC., ELECTROCHEM SOLUTIONS, INC., NEURONEXUS TECHNOLOGIES, INC., MICRO POWER ELECTRONICS, INC., PRECIMED INC. reassignment GREATBATCH, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT)
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551Spinal or peripheral nerve electrodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/06Devices, other than using radiation, for detecting or locating foreign bodies ; determining position of probes within or on the body of the patient
    • A61B5/061Determining position of a probe within the body employing means separate from the probe, e.g. sensing internal probe position employing impedance electrodes on the surface of the body
    • A61B5/064Determining position of a probe within the body employing means separate from the probe, e.g. sensing internal probe position employing impedance electrodes on the surface of the body using markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/08Detecting organic movements or changes, e.g. tumours, cysts, swellings
    • A61B8/0833Detecting organic movements or changes, e.g. tumours, cysts, swellings involving detecting or locating foreign bodies or organic structures
    • A61B8/0841Detecting organic movements or changes, e.g. tumours, cysts, swellings involving detecting or locating foreign bodies or organic structures for locating instruments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551Spinal or peripheral nerve electrodes
    • A61N1/0553Paddle shaped electrodes, e.g. for laminotomy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/36017External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/36021External stimulators, e.g. with patch electrodes for treatment of pain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36071Pain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36125Details of circuitry or electric components
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128Control systems
    • A61N1/36135Control systems using physiological parameters
    • A61N1/36139Control systems using physiological parameters with automatic adjustment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128Control systems
    • A61N1/36146Control systems specified by the stimulation parameters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128Control systems
    • A61N1/36146Control systems specified by the stimulation parameters
    • A61N1/3615Intensity
    • A61N1/36153Voltage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators
    • A61N1/37217Means for communicating with stimulators characterised by the communication link, e.g. acoustic or tactile
    • A61N1/37223Circuits for electromagnetic coupling
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators
    • A61N1/37235Aspects of the external programmer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators
    • A61N1/37252Details of algorithms or data aspects of communication system, e.g. handshaking, transmitting specific data or segmenting data
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/375Constructional arrangements, e.g. casings
    • A61N1/3752Details of casing-lead connections
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/378Electrical supply
    • A61N1/3787Electrical supply from an external energy source

Definitions

  • the present patent document pertains generally to peripheral field stimulation and more particularly, but not by way of limitation, to an implantable peripheral field stimulation apparatus, system, and method.
  • PNFS Peripheral nerve field stimulation
  • SCS spinal cord stimulation
  • Peripheral nerves can be defined as branches of peripheral nerves, groups of peripheral nerves, and/or larger areas of individual nerves.
  • the present inventor has further recognized, among other things, that the subject matter can be used for implantable peripheral nerve stimulation. To better illustrate the apparatuses, systems, and methods described herein, a non-limiting list of examples is provided here:
  • Example 1 can include subject matter that can include an apparatus configured for at least partial insertion in a living body.
  • the apparatus includes an elongate lead body including a proximal lead end and a distal lead end. At least one connector is disposed proximate the proximal lead end. At least one flexible conductive surface is disposed at least partially around the lead body proximate the distal lead end. At least one conductor extends within the lead body from the at least one connector to the at least one flexible conductive surface.
  • Example 2 the subject matter of Example 1 is optionally configured such that the at least one flexible conductive surface includes a mesh.
  • Example 3 the subject matter of any one of Examples 1-2 is optionally configured such that the at least one flexible conductive surface includes a coil.
  • Example 4 the subject matter of any one of Examples 1-3 is optionally configured such that the at least one flexible conductive surface is disposed completely around the lead body.
  • Example 5 the subject matter of any one of Examples 1-4 is optionally configured such that the at least one flexible conductive surface includes a length between 1 cm and 20 cm.
  • Example 6 the subject matter of any one of Examples 1-5 is optionally configured such that the at least one flexible conductive surface includes two or more flexible conductive surfaces.
  • Example 7 the subject matter of Example 6 is optionally configured such that the two or more flexible conductive surfaces includes at least three flexible conductive surfaces, wherein a center flexible conductive surface includes a first length; a distal flexible conductive surface disposed distally on the elongate lead body from the center flexible conductive surface and including a second length; and a proximal flexible conductive surface disposed proximally on the elongate lead body from the center flexible conductive surface and including a third length.
  • the second and third lengths are shorter than the first length.
  • Example 8 the subject matter of Example 7 is optionally configured such that the at least three flexible conductive surfaces are longitudinally spaced along the elongate lead body from one another.
  • Example 9 the subject matter of any one of Examples 7-8 is optionally configured such that the second length is substantially equal to the third length.
  • Example 10 the subject matter of any one of Examples 7-9 is optionally configured such that the first length is 12-16 mm and the second length and the third length are each 7-11 mm.
  • Example 11 the subject matter of any one of Examples 1-10 is optionally configured such that the at least one conductor extends within a lumen of the lead body.
  • Example 12 the subject matter of any one of Examples 1-11 is optionally configured such that the at least one conductor includes two or more conductors, wherein one of the conductors is disposed within a first lumen of the lead body and another of the conductors is disposed within a second lumen of the lead body.
  • Example 13 the subject matter of Example 12 is optionally configured such that the lead body includes a stylet lumen configured to accept a stylet within the stylet lumen.
  • Example 14 can include, or can optionally be combined with any one of Examples 1-13 to include subject matter that can include an apparatus configured for at least partial insertion in a living body.
  • the apparatus includes an elongate lead body including a proximal lead end, a distal lead end, and a lumen within the lead body.
  • a connector is disposed proximate the proximal lead end.
  • a flexible conductive surface is disposed at least partially around the lead body proximate the distal lead end.
  • a conductor extends within the lumen, the conductor extending from the connector to the flexible conductive surface.
  • Example 15 the subject matter of Example 14 is optionally configured such that the flexible conductive surface includes a mesh.
  • Example 16 the subject matter of any one of Examples 14-15 is optionally configured such that the flexible conductive surface includes a coil.
  • Example 17 the subject matter of any one of Examples 14-16 optionally includes at least a second flexible conductive surface disposed at least partially around the lead body proximate the distal lead end.
  • Example 18 can include, or can optionally be combined with any one of Examples 1-17 to include subject matter that can include an apparatus configured for at least partial insertion in a living body.
  • the apparatus includes an elongate lead body including a proximal lead end, a distal lead end, and at least one lumen within the lead body.
  • At least one connector is disposed proximate the proximal lead end.
  • At least one flexible conductive surface is disposed around the lead body proximate the distal lead end.
  • At least one conductor extends within the at least one lumen, the at least one conductor extending from the at least one connector to the at least one flexible conductive surface.
  • a stylet lumen is disposed within the lead body, the stylet lumen being configured to accept a stylet within the stylet lumen.
  • Example 19 the subject matter of Example 18 is optionally configured such that the flexible conductive surface includes a mesh.
  • Example 20 the subject matter of any one of Examples 18-19 is optionally configured such that the flexible conductive surface includes a coil.
  • FIG. 1 shows an apparatus including a flexible conductive surface in accordance with at least one example of the invention.
  • FIG. 2 shows an apparatus including a flexible conductive surface in accordance with at least one example of the invention.
  • FIG. 3 shows an apparatus including a flexible conductive surface in accordance with at least one example of the invention.
  • FIG. 4 shows a graph including data related to potential at various distances from an apparatus in accordance with at least one example of the invention.
  • FIG. 5 shows a graph including data related to potential at various distances from a spinal cord stimulation lead.
  • FIG. 6 shows an apparatus including a flexible conductive surface in accordance with at least one example of the invention.
  • FIG. 7 depicts current density profiles of apparatuses including flexible conductive surfaces in accordance with examples of the invention.
  • FIG. 8 shows an example of an apparatus in accordance with at least one example of the invention, the apparatus including multiple lumens.
  • FIGS. 9A-9C show example configurations of apparatuses in accordance with examples of the invention.
  • the present patent document relates to apparatuses, systems, and methods for peripheral field stimulation.
  • the apparatuses, systems, and methods of the present patent document are used, in some examples, to provide peripheral nerve field stimulation (PNFS) to extremities or other body segments.
  • PNFS peripheral nerve field stimulation
  • the present patent document relates to, among other things, stimulation of peripheral nerves.
  • Peripheral nerves can be defined as branches of peripheral nerves, groups of peripheral nerves, and/or larger areas of individual nerves.
  • the present inventor has recognized, among other things, that it is desirable to have PNFS apparatuses, systems, and methods which include one or more flexible conductive surfaces.
  • the present inventor has further recognized, among other things, that it is desirable to have PNFS apparatuses, systems, and methods configured to generate a broad field.
  • the present inventor has further recognized, among other things, that it is desirable to have PNFS apparatuses, systems, and methods configured for placement in patient extremities or other body segments. It should be understood, however, that the subject matter described herein can be used with other implantable medical devices, as well as an external device in some examples.
  • SCS Spinal cord stimulation
  • One challenge is that SCS lead contacts are usually only about 3 mm in length. This length was chosen for SCS as a good compromise between DC fiber selectivity, moderate impedance, enough focal current density, and ease of manufacturability.
  • selectivity and focal current density are relatively unimportant in PNFS, as the stimulation goal is to generate as broad a field as is comfortably possible.
  • Most SCS leads cover no more than 6 cm, and they do this by using contacts that are separated by several millimeters of insulator. Even when these leads are programmed with all the same polarity, the field near the contacts still undulates in space and this can promote activation of fibers near the contacts rather than further away. And, the moderate impedance that results from small SCS contacts is likely too high for PNFS.
  • the contacts are typically rigid metallic cylinders, which can be useful in SCS to provide mechanical stability for lead positioning within the bony canal of the spine, as well as for a robust substrate for current/voltage delivery.
  • electrode contact length and rigidity can make them difficult to position over curved body regions such as a leg or a skull, or around bony structures, and may promote skin erosion or lead breakage over time.
  • PNFS has been employed primarily in the trunk to treat overall back pain and this has been reasonably successful. What has not been addressed is that patients often have focal pain in extremities that would better benefit by deployment of PNFS stimulation in those regions.
  • the power requirements of PNFS are similar to SCS, so the use of traditional SCS systems in extremity PNFS is challenged from both a stimulator size and power problem, i.e., the batteries have to be large enough to support the required stimulation power, yet such sizes cannot be implanted on the extremities because of anatomic, cosmesis, and comfort concerns.
  • long flexible grossly-cylindrical conductive surfaces act as stimulation electrodes and are deployed along a flexible lead for subcutaneous placement and stimulation of surrounding tissue.
  • the distribution of different lengths of flexible conductors is provided in a manner intended to equalize the relative current passing through each conductive surface to the tissue.
  • the present systems, apparatuses, and methods allow for the connection of one or more stimulating leads to a microstimulator deployable on the same body segment as the connected leads is provided.
  • an apparatus 100 is configured for at least partial insertion in a living body.
  • the apparatus 100 is a stimulation lead for selective attachment to a stimulation device, such as, for instance, a microstimulator.
  • a stimulation device such as, for instance, a microstimulator.
  • the apparatus can include other at least partially implantable devices.
  • the apparatus 100 includes an elongate lead body 102 including a proximal lead end 102 A and a distal lead end 102 B.
  • at least one connector 104 is disposed proximate the proximal lead end 102 A.
  • the at least one connector 104 is configured to electrically couple to the stimulation device.
  • at least one flexible conductive surface 110 is disposed at least partially around the lead body 102 proximate the distal lead end 102 B. In some examples, the at least one flexible conductive surface 110 is disposed completely around the lead body 102 .
  • the apparatus 100 further includes, in some examples, at least one conductor 106 extending within the lead body 102 from the at least one connector 104 to the at least one flexible conductive surface 110 .
  • the at least one conductor 106 extends within a lumen 103 of the lead body 102 .
  • the apparatus 100 includes one flexible conductor 110 . In other examples, the apparatus 100 includes two or more flexible conductive surfaces 110 separated by a distance. In some examples, the apparatus 100 includes a plurality of flexible conductive surfaces 110 . In the example shown in FIG. 1 , the apparatus 100 includes seven flexible conductive surfaces 110 . In other examples, the apparatus 100 can include more or fewer than seven flexible conductive surfaces 110 . In some examples, each of the flexible conductive surfaces 110 is substantially the same length. In other examples, the flexible conductive surfaces 110 include different lengths. In some examples, the flexible conductive surfaces 110 are longitudinally spaced along the lead body 102 . In some examples, spacing between each of the flexible conductive surfaces 110 is substantially similar. In other examples, spacing between each of the flexible conductive surfaces 110 varies.
  • the at least one flexible conductive surface 110 includes a mesh.
  • the at least one flexible conductive surface 110 is made of a metal mesh that envelopes the circumference of the lead body 102 .
  • the mesh of the at least one flexible conductive surface 110 can include a ‘rough’ surface that increases the geometric surface area of the at least one flexible conductive surface 110 . In some instances, this increased geometric surface area can reduce the resistance while increasing the reactance of the effective electrode of the at least one flexible conductive surface 110 . By doing so, in some examples, the voltage to generate a specific current is reduced throughout the stimulation portion of the waveform, which can save battery power.
  • the mesh can include an arrangement of single cross-hatched, braided, or otherwise disposed or applied conductors; an arrangement of multistranded cross-hatched, braided, or otherwise disposed or applied conductors, and/or a variety of deposited thin film conductive elements, to name a few.
  • an apparatus 200 is configured for at least partial insertion in a living body.
  • the apparatus 200 is a stimulation lead for selective attachment to a stimulation device, such as, for instance, a microstimulator.
  • a stimulation device such as, for instance, a microstimulator.
  • the apparatus can include other at least partially implantable devices.
  • the apparatus 200 includes an elongate lead body 202 including a proximal lead end 202 A and a distal lead end 202 B.
  • at least one connector 204 is disposed proximate the proximal lead end 202 A.
  • the at least one connector 204 is configured to electrically couple to the stimulation device.
  • at least one flexible conductive surface 210 is disposed at least partially around the lead body 202 proximate the distal lead end 202 B. In some examples, the at least one flexible conductive surface 210 is disposed completely around the lead body 202 .
  • the apparatus 200 further includes, in some examples, at least one conductor 206 extending within the lead body 202 from the at least one connector 204 to the at least one flexible conductive surface 210 .
  • the at least one conductor 206 extends within a lumen 203 of the lead body 202 .
  • the apparatus 200 includes one flexible conductor 210 . In other examples, the apparatus 200 includes two or more flexible conductive surfaces 210 separated by a distance. In some examples, the apparatus 200 includes a plurality of flexible conductive surfaces 210 . In the example shown in FIG. 2 , the apparatus 200 includes six flexible conductive surfaces 210 . In other examples, the apparatus 200 can include more or fewer than six flexible conductive surfaces 210 . In some examples, each of the flexible conductive surfaces 210 is substantially the same length. In other examples, the flexible conductive surfaces 210 include different lengths. In some examples, the flexible conductive surfaces 210 are longitudinally spaced along the lead body 202 . In some examples, spacing between each of the flexible conductive surfaces 210 is substantially similar. In other examples, spacing between each of the flexible conductive surfaces 210 varies.
  • the at least one flexible conductive surface 210 includes a coil.
  • the at least one flexible conductive surface 210 is made of a coiled wire.
  • the coil can include an arrangement of single conductors; an arrangement of multistranded conductors, and/or a variety of deposited thin film conductive elements, to name a few.
  • the coil of the at least one flexible conductive surface 210 envelopes the circumference of the lead body 202 .
  • the at least one flexible conductive surface 210 including a coil includes a benefit of increasing the geometric surface area relative to, for instance, a flat surface.
  • an apparatus 300 is configured for at least partial insertion in a living body.
  • the apparatus 300 is a stimulation lead for selective attachment to a stimulation device, such as, for instance, a microstimulator.
  • a stimulation device such as, for instance, a microstimulator.
  • the apparatus can include other at least partially implantable devices.
  • the apparatus 300 includes an elongate lead body 302 including a proximal lead end 302 A and a distal lead end 302 B.
  • at least one connector 304 is disposed proximate the proximal lead end 302 A.
  • the at least one connector 304 is configured to electrically couple to the stimulation device.
  • a flexible conductive surface 310 is disposed at least partially around the lead body 302 proximate the distal lead end 302 B. In some examples, the flexible conductive surface 310 is disposed completely around the lead body 302 .
  • the apparatus 300 further includes, in some examples, at least one conductor 306 extending within the lead body 302 from the at least one connector 304 to the flexible conductive surface 310 .
  • the at least one conductor 306 extends within a lumen 303 of the lead body 302 .
  • the flexible conductive surface 310 includes a mesh.
  • the flexible conductive surface 310 is made of a metal mesh that envelopes the circumference of the lead body 302 .
  • the mesh of the flexible conductive surface 310 can include a ‘rough’ surface that increases the geometric surface area of the flexible conductive surface 310 . In some instances, this increased geometric surface area can reduce the resistance while increasing the reactance of the effective electrode of the flexible conductive surface 310 . By doing so, in some examples, the voltage to generate a specific current is reduced throughout the stimulation portion of the waveform, which can save battery power.
  • the mesh can include an arrangement of single cross-hatched, braided, or otherwise disposed or applied conductors; an arrangement of multistranded cross-hatched, braided, or otherwise disposed or applied conductors, and/or a variety of deposited thin film conductive elements, to name a few.
  • the flexible conductive surface can include a coil, for instance, similar to the at least one flexible conductive surface 210 described herein.
  • the coil can include an arrangement of single conductors; an arrangement of multistranded conductors, and/or a variety of deposited thin film conductive elements, to name a few.
  • the apparatus 300 includes one relatively long flexible conductor per lead body 302 .
  • the flexible conductive surface 310 includes a length between 1 cm and 20 cm along the lead body 302 . In some examples, this has the advantage of relatively simple manufacture as well as simple programming. Additionally, in some examples, when programmed with a single polarity, this unbroken isopotential surface can reduce the undulating field that occurs when separated contacts are used, such as found on traditional SCS-type leads that have spaced-apart contacts, as seen in FIGS. 4 and 5 .
  • FIG. 4 shows potential at various distances from a stimulation lead similar to the apparatus 300 having a single continuous flexible conductive surface that is 6 cm in length.
  • FIG. 5 comparatively shows potential at various distances from a spinal cord stimulation lead having 6 mm contacts with 9 mm spacing.
  • the potential of the single continuous flexible conductive surface lead ( FIG. 4 ) is smoother than the potential of the spinal cord stimulation lead ( FIG. 5 ).
  • the smoother potential near the single continuous flexible conductive surface lead can reduce the likelihood that close neural structures are preferentially activated compared to further neural structures, ideally resulting in a broader area of activation.
  • an apparatus 600 is configured for at least partial insertion in a living body.
  • the apparatus 600 is a stimulation lead for selective attachment to a stimulation device, such as, for instance, a microstimulator.
  • a stimulation device such as, for instance, a microstimulator.
  • the apparatus can include other at least partially implantable devices.
  • the apparatus 600 includes an elongate lead body 602 including a proximal lead end 602 A′, 602 A′′ and a distal lead end 602 B.
  • at least one connector 604 ′ is disposed proximate the proximal lead end 602 A′.
  • the at least one connector 604 ′ includes a plug-like connector for engagement with the stimulation device.
  • the connector 604 ′′ includes one or more contacts 605 ′′ disposed in-line longitudinally along the lead body 602 proximate the proximal lead end 602 A′′ of the lead body 602 .
  • the at least one connector 604 ′, 604 ′′ is configured to electrically couple to the stimulation device.
  • a plurality of flexible conductive surfaces 610 is disposed at least partially around the lead body 602 proximate the distal lead end 602 B. In some examples, the plurality of flexible conductive surfaces 610 is disposed completely around the lead body 602 .
  • the apparatus 600 further includes, in some examples, at least one conductor 606 extending within the lead body 602 from the at least one connector 604 ′, 604 ′′ to the plurality of flexible conductive surfaces 610 . In some examples, the at least one conductor 606 extends within a lumen 603 of the lead body 602 .
  • the apparatus 600 includes at least three flexible conductive surfaces including a center flexible conductive surface 610 A including a first length, a distal flexible conductive surface 610 B disposed distally on the elongate lead body 602 from the center flexible conductive surface 610 A and including a second length, and a proximal flexible conductive surface 610 C disposed proximally on the elongate lead body 602 from the center flexible conductive surface 610 A and including a third length.
  • the second and third lengths of the being shorter than the first length.
  • the at least three flexible conductive surfaces 610 A, 610 B, 610 C are longitudinally spaced along the elongate lead body 602 from one another.
  • the second length is substantially equal to the third length.
  • the first length is about 12-16 mm and the second length and the third length are each about 7-11 mm.
  • the flexible conductive surfaces 610 are longitudinally spaced along the lead body 602 . In some examples, spacing between each of the flexible conductive surfaces 610 is substantially similar. In other examples, spacing between each of the flexible conductive surfaces 610 varies.
  • the flexible conductive surfaces 610 have different lengths along the lead body 602 .
  • the apparatus 600 includes seven flexible conductive surfaces 610 , with the center flexible conductive surface 610 A; three distal flexible conductive surfaces 610 B, 610 D, 610 F disposed distally from the center conductive surface 610 A; and three proximal flexible conductive surfaces 610 C, 610 E, 610 G disposed proximally from the center conductive surface 610 A, with the length of the center flexible conductive surface 610 A being the longest and the lengths of the three distal flexible conductive surfaces 610 B, 610 D, 610 F and the three proximal flexible conductive surfaces 610 C, 610 E, 610 G getting shorter the farther from the center flexible conductive surface 610 A they are.
  • a symmetrical pattern is used in which the largest flexible conductive surface 610 A is positioned at the center of the contact array, for instance, approximately 12-16 mm in length; the next largest flexible conductive surfaces 610 B, 610 C flank the center flexible conductive surface 610 A, one to each side and are longer, for instance, approximately 7-11 mm in length; the next smallest flexible conductive surfaces 610 D, 610 E flank those outer contacts 610 B, 610 C, and are shorter in length than the outer contacts 610 B, 610 C; and so on.
  • this decreasing length-from-center pattern is continued for the desired full length of the conductor array along the lead body 602 , for instance, approximately 6-20 cm in total.
  • this decreasing length-from-center pattern is done to have the current density delivered from the lead be grossly-but-evenly distributed along the array length when connected to a simple single source (voltage or current) stimulation system. This allows for redistribution of current density “hot spots,” which occur near the edge of a single conductive surface, as seen in FIG. 7 . If the flexible conductive surface is very long (for instance, the flexible conductive surface 310 of the lead body 302 of FIG. 7 ), then the resistive impedance is relatively low, and, with all the surface current leaving the edge of the contact, current density 311 will be relatively high toward the edges and relatively low therebetween. In some embodiments, the different length electrodes (for instance, the flexible conductive surfaces 610 of the lead body 602 of FIG.
  • the apparatus 600 can include more or fewer than seven flexible conductive surfaces 610 .
  • the apparatus 600 can include flexible conductive surfaces 610 of various lengths tailored to the particular application for which the apparatus 600 is being used. As such, it is contemplated in various examples, that the flexible conductive surfaces 610 can include any combination of lengths desired for peripheral nerve stimulation.
  • each of the flexible conductive surfaces 610 includes a mesh.
  • each of the flexible conductive surfaces 610 is made of a metal mesh that envelopes the circumference of the lead body 602 .
  • the mesh of each of the flexible conductive surfaces 610 can include a ‘rough’ surface that increases the geometric surface area of each of flexible conductive surfaces 610 . In some instances, this increased geometric surface area can reduce the resistance while increasing the reactance of the effective electrode of each of the flexible conductive surfaces 610 . By doing so, in some examples, the voltage to generate a specific current is reduced throughout the stimulation portion of the waveform, which can save battery power.
  • the mesh can include an arrangement of single crosshatched, braided, or otherwise disposed or applied conductors; an arrangement of multistranded crosshatched, braided, or otherwise disposed or applied conductors, and/or a variety of deposited thin film conductive elements, to name a few.
  • each of the flexible conductive surfaces can include a coil, for instance, similar to the at least one flexible conductive surface 210 described herein.
  • the coil can include an arrangement of single conductors; an arrangement of multistranded conductors, and/or a variety of deposited thin film conductive elements, to name a few.
  • a lead body 802 (which can be used in any of the apparatuses 100 , 200 , 300 , 600 described herein) includes multiple lumens 803 , 807 .
  • the lead body 802 includes two or more conductors, wherein one of the conductors is disposed within a first lumen 807 of the lead body 802 and another of the conductors is disposed within a second lumen 807 of the lead body 802 .
  • the lead body 802 includes multiple inner lumens 807 which allow multiple conductors to traverse the lead body 802 to their respective flexible conductive surfaces without abrasion against other conductors.
  • the lead body 802 includes a stylet lumen 803 configured to accept a stylet within the stylet lumen 803 .
  • the lead body 802 includes a central lumen 803 to allow for a stylet to be passed through the lead body 802 , which can be used to stiffen and/or curve the lead body 802 , for instance, for tortuous or obstructed tissue pathways and/or to curve around tissue planes.
  • the lead body 802 including multiple lumens 803 , 807 allows for improved handling and/or maneuverability of the lead body 802 .
  • stimulation systems 900 A, 900 B, 900 C are shown in some exemplary implanted locations. It should be understood that these implant locations are merely exemplary and that it is contemplated that the stimulation systems 940 A, 940 B, 940 C can be implanted in various other locations of the body that are not specifically shown herein.
  • one or more stimulation leads 900 A, 900 B, 900 C with flexible conductive surfaces are connected to a microstimulator 950 A, 950 B, 950 C.
  • the microstimulators 950 A, 950 B, 950 C are present on the same body segment as the respective one or more stimulation leads 900 A, 900 B, 900 C. In this way, by not traversing a joint with the stimulation leads 900 A, 900 B, 900 C, the chances of any one or more of lead damage, lead dislodgment, lead migration, skin erosion, lead-stimulator uncoupling, and lead fatigue are decreased.
  • the body segments include: a thigh 10 ( FIG. 9A ), a calf/shin, a forearm, an upper arm 20 ( FIG. 9B ), a neck 30 ( FIG.
  • the stimulation system 940 A, 940 B, 940 C includes stimulation leads 900 A, 900 B, 900 C that are of appropriate length to allow for placement within or nearby the therapy target, some looping to inhibit tension from creating migration of the stimulation lead 900 A, 900 B, 900 C, and/or connection to the microstimulator 950 A, 950 B, 950 C, all implanted within that body segment 10 , 20 , 30 .
  • the lead (for instance, any of the apparatuses 100 , 200 , 300 , 600 , 900 A, 900 B, 900 C) has a relative small diameter, ranging between about 0.1 mm and about 1 mm. In some examples, this allows for better ability to place and position the lead over areas with thin regions of soft tissue, such as the skull, for instance, improving cosmesis as well as reducing the likelihood of erosion.
  • the lead body 102 , 202 , 302 , 602 is made of a biocompatible polymer, which is flexible and durable within the body. In some examples, this can be advantageous for extremities, which are typically in motion and undergo shape changes and make frequent contact with the outside world during activities of daily living.
  • peripheral nerves may be directly targeted to mitigate chronic pain of limbs, for instance.
  • the various flexible conductive surfaces 110 , 210 , 310 , 610 described herein allow for increased flexibility of the respective lead bodies 102 , 202 , 302 , 602 , allowing for better body conformance, increased comfort, decreased skin erosion, and the like. Additionally, the various flexible conductive surfaces 110 , 210 , 310 , 610 described herein allow for increased contact, leading to more effective and efficient use of power, which, in some examples, can be advantageous due to the desired smaller size of components. In some examples, the various flexible conductive surfaces 110 , 210 , 310 , 610 described herein allow for stimulation of a relatively wide area with relatively low power needed to do so.
  • the apparatuses, systems, and methods described herein can be used to better provide PNFS using one or more flexible conductive surfaces.
  • the apparatuses, systems, and methods described herein are considered advantageous in that they allow for generation of a broad field to provide better PNFS.
  • the apparatuses, systems, and methods described herein include PNFS apparatuses, systems, and methods sized, shaped, or otherwise configured for placement in patient extremities or other body segments. While various advantages of the example apparatuses, systems, and methods are listed herein, this list is not considered to be complete, as further advantages may become apparent from the description and figures presented herein.
  • the terms “a” or “an” are used to include one or more than one, independent of any other instances or usages of “at least one” or “one or more.”
  • the term “or” is used to refer to a nonexclusive or, such that “A or B” includes “A but not B,” “B but not A,” and “A and B,” unless otherwise indicated.
  • the terms “about” and “approximately” or similar are used to refer to an amount that is nearly, almost, or in the vicinity of being equal to a stated amount.

Abstract

In various examples, an apparatus is configured for at least partial insertion in a living body. The apparatus includes an elongate lead body including a proximal lead end and a distal lead end. At least one connector is disposed proximate the proximal lead end. At least one flexible conductive surface is disposed at least partially around the lead body proximate the distal lead end. At least one conductor extends within the lead body from the at least one connector to the at least one flexible conductive surface.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application claims the benefit of priority to U.S. Provisional Application Ser. No. 61/841,965, filed on Jul. 2, 2013, entitled “STIMULATION APPARATUSES, DEVICES, SYSTEMS, AND METHODS,” which is incorporated by reference herein in its entirety.
  • TECHNICAL FIELD
  • The present patent document pertains generally to peripheral field stimulation and more particularly, but not by way of limitation, to an implantable peripheral field stimulation apparatus, system, and method.
  • BACKGROUND
  • Peripheral nerve field stimulation (PNFS), where multicontact percutaneous leads are positioned underneath the skin, recruits nerve fiber endings and axons in the cutaneous and subcutaneous layers, usually within a few centimeters of the electrodes. Traditional lead designs for spinal cord stimulation (SCS) are often used for PNFS. While these can provide adequate coverage, SCS systems have certain challenges when used in PNFS applications.
  • OVERVIEW
  • This overview is intended to provide an overview of subject matter of the present patent application. It is not intended to provide an exclusive or exhaustive explanation of the invention. The detailed description is included to provide further information about the present patent application.
  • The present inventor has recognized, among other things, that the subject matter can be used for stimulation of peripheral nerves. Peripheral nerves can be defined as branches of peripheral nerves, groups of peripheral nerves, and/or larger areas of individual nerves. The present inventor has further recognized, among other things, that the subject matter can be used for implantable peripheral nerve stimulation. To better illustrate the apparatuses, systems, and methods described herein, a non-limiting list of examples is provided here:
  • Example 1 can include subject matter that can include an apparatus configured for at least partial insertion in a living body. The apparatus includes an elongate lead body including a proximal lead end and a distal lead end. At least one connector is disposed proximate the proximal lead end. At least one flexible conductive surface is disposed at least partially around the lead body proximate the distal lead end. At least one conductor extends within the lead body from the at least one connector to the at least one flexible conductive surface.
  • In Example 2, the subject matter of Example 1 is optionally configured such that the at least one flexible conductive surface includes a mesh.
  • In Example 3, the subject matter of any one of Examples 1-2 is optionally configured such that the at least one flexible conductive surface includes a coil.
  • In Example 4, the subject matter of any one of Examples 1-3 is optionally configured such that the at least one flexible conductive surface is disposed completely around the lead body.
  • In Example 5, the subject matter of any one of Examples 1-4 is optionally configured such that the at least one flexible conductive surface includes a length between 1 cm and 20 cm.
  • In Example 6, the subject matter of any one of Examples 1-5 is optionally configured such that the at least one flexible conductive surface includes two or more flexible conductive surfaces.
  • In Example 7, the subject matter of Example 6 is optionally configured such that the two or more flexible conductive surfaces includes at least three flexible conductive surfaces, wherein a center flexible conductive surface includes a first length; a distal flexible conductive surface disposed distally on the elongate lead body from the center flexible conductive surface and including a second length; and a proximal flexible conductive surface disposed proximally on the elongate lead body from the center flexible conductive surface and including a third length. The second and third lengths are shorter than the first length.
  • In Example 8, the subject matter of Example 7 is optionally configured such that the at least three flexible conductive surfaces are longitudinally spaced along the elongate lead body from one another.
  • In Example 9, the subject matter of any one of Examples 7-8 is optionally configured such that the second length is substantially equal to the third length.
  • In Example 10, the subject matter of any one of Examples 7-9 is optionally configured such that the first length is 12-16 mm and the second length and the third length are each 7-11 mm.
  • In Example 11, the subject matter of any one of Examples 1-10 is optionally configured such that the at least one conductor extends within a lumen of the lead body.
  • In Example 12, the subject matter of any one of Examples 1-11 is optionally configured such that the at least one conductor includes two or more conductors, wherein one of the conductors is disposed within a first lumen of the lead body and another of the conductors is disposed within a second lumen of the lead body.
  • In Example 13, the subject matter of Example 12 is optionally configured such that the lead body includes a stylet lumen configured to accept a stylet within the stylet lumen.
  • Example 14 can include, or can optionally be combined with any one of Examples 1-13 to include subject matter that can include an apparatus configured for at least partial insertion in a living body. The apparatus includes an elongate lead body including a proximal lead end, a distal lead end, and a lumen within the lead body. A connector is disposed proximate the proximal lead end. A flexible conductive surface is disposed at least partially around the lead body proximate the distal lead end. A conductor extends within the lumen, the conductor extending from the connector to the flexible conductive surface.
  • In Example 15, the subject matter of Example 14 is optionally configured such that the flexible conductive surface includes a mesh.
  • In Example 16, the subject matter of any one of Examples 14-15 is optionally configured such that the flexible conductive surface includes a coil.
  • In Example 17, the subject matter of any one of Examples 14-16 optionally includes at least a second flexible conductive surface disposed at least partially around the lead body proximate the distal lead end.
  • Example 18 can include, or can optionally be combined with any one of Examples 1-17 to include subject matter that can include an apparatus configured for at least partial insertion in a living body. The apparatus includes an elongate lead body including a proximal lead end, a distal lead end, and at least one lumen within the lead body. At least one connector is disposed proximate the proximal lead end. At least one flexible conductive surface is disposed around the lead body proximate the distal lead end. At least one conductor extends within the at least one lumen, the at least one conductor extending from the at least one connector to the at least one flexible conductive surface. A stylet lumen is disposed within the lead body, the stylet lumen being configured to accept a stylet within the stylet lumen.
  • In Example 19, the subject matter of Example 18 is optionally configured such that the flexible conductive surface includes a mesh.
  • In Example 20, the subject matter of any one of Examples 18-19 is optionally configured such that the flexible conductive surface includes a coil.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 shows an apparatus including a flexible conductive surface in accordance with at least one example of the invention.
  • FIG. 2 shows an apparatus including a flexible conductive surface in accordance with at least one example of the invention.
  • FIG. 3 shows an apparatus including a flexible conductive surface in accordance with at least one example of the invention.
  • FIG. 4 shows a graph including data related to potential at various distances from an apparatus in accordance with at least one example of the invention.
  • FIG. 5 shows a graph including data related to potential at various distances from a spinal cord stimulation lead.
  • FIG. 6 shows an apparatus including a flexible conductive surface in accordance with at least one example of the invention.
  • FIG. 7 depicts current density profiles of apparatuses including flexible conductive surfaces in accordance with examples of the invention.
  • FIG. 8 shows an example of an apparatus in accordance with at least one example of the invention, the apparatus including multiple lumens.
  • FIGS. 9A-9C show example configurations of apparatuses in accordance with examples of the invention.
  • DETAILED DESCRIPTION
  • The present patent document relates to apparatuses, systems, and methods for peripheral field stimulation. For instance, the apparatuses, systems, and methods of the present patent document are used, in some examples, to provide peripheral nerve field stimulation (PNFS) to extremities or other body segments. The present patent document relates to, among other things, stimulation of peripheral nerves. Peripheral nerves can be defined as branches of peripheral nerves, groups of peripheral nerves, and/or larger areas of individual nerves.
  • The present inventor has recognized, among other things, that it is desirable to have PNFS apparatuses, systems, and methods which include one or more flexible conductive surfaces. The present inventor has further recognized, among other things, that it is desirable to have PNFS apparatuses, systems, and methods configured to generate a broad field. The present inventor has further recognized, among other things, that it is desirable to have PNFS apparatuses, systems, and methods configured for placement in patient extremities or other body segments. It should be understood, however, that the subject matter described herein can be used with other implantable medical devices, as well as an external device in some examples.
  • Spinal cord stimulation (SCS) systems have certain challenges when used in PNFS applications. One challenge is that SCS lead contacts are usually only about 3 mm in length. This length was chosen for SCS as a good compromise between DC fiber selectivity, moderate impedance, enough focal current density, and ease of manufacturability. However, selectivity and focal current density are relatively unimportant in PNFS, as the stimulation goal is to generate as broad a field as is comfortably possible. Most SCS leads cover no more than 6 cm, and they do this by using contacts that are separated by several millimeters of insulator. Even when these leads are programmed with all the same polarity, the field near the contacts still undulates in space and this can promote activation of fibers near the contacts rather than further away. And, the moderate impedance that results from small SCS contacts is likely too high for PNFS.
  • Additionally, the contacts are typically rigid metallic cylinders, which can be useful in SCS to provide mechanical stability for lead positioning within the bony canal of the spine, as well as for a robust substrate for current/voltage delivery. In PNFS, however, electrode contact length and rigidity can make them difficult to position over curved body regions such as a leg or a skull, or around bony structures, and may promote skin erosion or lead breakage over time.
  • Finally, PNFS has been employed primarily in the trunk to treat overall back pain and this has been reasonably successful. What has not been addressed is that patients often have focal pain in extremities that would better benefit by deployment of PNFS stimulation in those regions. In addition, the power requirements of PNFS are similar to SCS, so the use of traditional SCS systems in extremity PNFS is challenged from both a stimulator size and power problem, i.e., the batteries have to be large enough to support the required stimulation power, yet such sizes cannot be implanted on the extremities because of anatomic, cosmesis, and comfort concerns.
  • What is needed includes stimulation systems, apparatuses, and methods that can provide PNFS to extremities using a stimulation system designed to meet the requirements of PNFS. To that end, and with reference to FIGS. 1-9C, various examples are contemplated herein. In some embodiments, long flexible grossly-cylindrical conductive surfaces act as stimulation electrodes and are deployed along a flexible lead for subcutaneous placement and stimulation of surrounding tissue. In some embodiments, the distribution of different lengths of flexible conductors is provided in a manner intended to equalize the relative current passing through each conductive surface to the tissue. In some embodiments, the present systems, apparatuses, and methods allow for the connection of one or more stimulating leads to a microstimulator deployable on the same body segment as the connected leads is provided.
  • Referring to FIG. 1, an apparatus 100 is configured for at least partial insertion in a living body. In some examples, the apparatus 100 is a stimulation lead for selective attachment to a stimulation device, such as, for instance, a microstimulator. Although described primarily herein with respect to stimulation leads, it should be understood that, in other examples, the apparatus can include other at least partially implantable devices.
  • In some examples, the apparatus 100 includes an elongate lead body 102 including a proximal lead end 102A and a distal lead end 102B. In some examples, at least one connector 104 is disposed proximate the proximal lead end 102A. In some examples, the at least one connector 104 is configured to electrically couple to the stimulation device. In some examples, at least one flexible conductive surface 110 is disposed at least partially around the lead body 102 proximate the distal lead end 102B. In some examples, the at least one flexible conductive surface 110 is disposed completely around the lead body 102. The apparatus 100 further includes, in some examples, at least one conductor 106 extending within the lead body 102 from the at least one connector 104 to the at least one flexible conductive surface 110. In some examples, the at least one conductor 106 extends within a lumen 103 of the lead body 102.
  • In some examples, the apparatus 100 includes one flexible conductor 110. In other examples, the apparatus 100 includes two or more flexible conductive surfaces 110 separated by a distance. In some examples, the apparatus 100 includes a plurality of flexible conductive surfaces 110. In the example shown in FIG. 1, the apparatus 100 includes seven flexible conductive surfaces 110. In other examples, the apparatus 100 can include more or fewer than seven flexible conductive surfaces 110. In some examples, each of the flexible conductive surfaces 110 is substantially the same length. In other examples, the flexible conductive surfaces 110 include different lengths. In some examples, the flexible conductive surfaces 110 are longitudinally spaced along the lead body 102. In some examples, spacing between each of the flexible conductive surfaces 110 is substantially similar. In other examples, spacing between each of the flexible conductive surfaces 110 varies.
  • In some examples, the at least one flexible conductive surface 110 includes a mesh. In some examples, the at least one flexible conductive surface 110 is made of a metal mesh that envelopes the circumference of the lead body 102. In some embodiments, the mesh of the at least one flexible conductive surface 110 can include a ‘rough’ surface that increases the geometric surface area of the at least one flexible conductive surface 110. In some instances, this increased geometric surface area can reduce the resistance while increasing the reactance of the effective electrode of the at least one flexible conductive surface 110. By doing so, in some examples, the voltage to generate a specific current is reduced throughout the stimulation portion of the waveform, which can save battery power. In some examples, the mesh can include an arrangement of single cross-hatched, braided, or otherwise disposed or applied conductors; an arrangement of multistranded cross-hatched, braided, or otherwise disposed or applied conductors, and/or a variety of deposited thin film conductive elements, to name a few.
  • Referring to FIG. 2, an apparatus 200 is configured for at least partial insertion in a living body. In some examples, the apparatus 200 is a stimulation lead for selective attachment to a stimulation device, such as, for instance, a microstimulator. Although described primarily herein with respect to stimulation leads, it should be understood that, in other examples, the apparatus can include other at least partially implantable devices.
  • In some examples, the apparatus 200 includes an elongate lead body 202 including a proximal lead end 202A and a distal lead end 202B. In some examples, at least one connector 204 is disposed proximate the proximal lead end 202A. In some examples, the at least one connector 204 is configured to electrically couple to the stimulation device. In some examples, at least one flexible conductive surface 210 is disposed at least partially around the lead body 202 proximate the distal lead end 202B. In some examples, the at least one flexible conductive surface 210 is disposed completely around the lead body 202. The apparatus 200 further includes, in some examples, at least one conductor 206 extending within the lead body 202 from the at least one connector 204 to the at least one flexible conductive surface 210. In some examples, the at least one conductor 206 extends within a lumen 203 of the lead body 202.
  • In some examples, the apparatus 200 includes one flexible conductor 210. In other examples, the apparatus 200 includes two or more flexible conductive surfaces 210 separated by a distance. In some examples, the apparatus 200 includes a plurality of flexible conductive surfaces 210. In the example shown in FIG. 2, the apparatus 200 includes six flexible conductive surfaces 210. In other examples, the apparatus 200 can include more or fewer than six flexible conductive surfaces 210. In some examples, each of the flexible conductive surfaces 210 is substantially the same length. In other examples, the flexible conductive surfaces 210 include different lengths. In some examples, the flexible conductive surfaces 210 are longitudinally spaced along the lead body 202. In some examples, spacing between each of the flexible conductive surfaces 210 is substantially similar. In other examples, spacing between each of the flexible conductive surfaces 210 varies.
  • In some examples, the at least one flexible conductive surface 210 includes a coil. In some examples, the at least one flexible conductive surface 210 is made of a coiled wire. In some examples, the coil can include an arrangement of single conductors; an arrangement of multistranded conductors, and/or a variety of deposited thin film conductive elements, to name a few. In some examples, the coil of the at least one flexible conductive surface 210 envelopes the circumference of the lead body 202. In some examples, the at least one flexible conductive surface 210 including a coil includes a benefit of increasing the geometric surface area relative to, for instance, a flat surface.
  • Referring to FIG. 3, an apparatus 300 is configured for at least partial insertion in a living body. In some examples, the apparatus 300 is a stimulation lead for selective attachment to a stimulation device, such as, for instance, a microstimulator. Although described primarily herein with respect to stimulation leads, it should be understood that, in other examples, the apparatus can include other at least partially implantable devices.
  • In some examples, the apparatus 300 includes an elongate lead body 302 including a proximal lead end 302A and a distal lead end 302B. In some examples, at least one connector 304 is disposed proximate the proximal lead end 302A. In some examples, the at least one connector 304 is configured to electrically couple to the stimulation device. In some examples, a flexible conductive surface 310 is disposed at least partially around the lead body 302 proximate the distal lead end 302B. In some examples, the flexible conductive surface 310 is disposed completely around the lead body 302. The apparatus 300 further includes, in some examples, at least one conductor 306 extending within the lead body 302 from the at least one connector 304 to the flexible conductive surface 310. In some examples, the at least one conductor 306 extends within a lumen 303 of the lead body 302.
  • In some examples, the flexible conductive surface 310 includes a mesh. In some examples, the flexible conductive surface 310 is made of a metal mesh that envelopes the circumference of the lead body 302. In some embodiments, the mesh of the flexible conductive surface 310 can include a ‘rough’ surface that increases the geometric surface area of the flexible conductive surface 310. In some instances, this increased geometric surface area can reduce the resistance while increasing the reactance of the effective electrode of the flexible conductive surface 310. By doing so, in some examples, the voltage to generate a specific current is reduced throughout the stimulation portion of the waveform, which can save battery power. In some examples, the mesh can include an arrangement of single cross-hatched, braided, or otherwise disposed or applied conductors; an arrangement of multistranded cross-hatched, braided, or otherwise disposed or applied conductors, and/or a variety of deposited thin film conductive elements, to name a few. In other examples, the flexible conductive surface can include a coil, for instance, similar to the at least one flexible conductive surface 210 described herein. In some examples, the coil can include an arrangement of single conductors; an arrangement of multistranded conductors, and/or a variety of deposited thin film conductive elements, to name a few. In some examples, the apparatus 300 includes one relatively long flexible conductor per lead body 302. In some examples, the flexible conductive surface 310 includes a length between 1 cm and 20 cm along the lead body 302. In some examples, this has the advantage of relatively simple manufacture as well as simple programming. Additionally, in some examples, when programmed with a single polarity, this unbroken isopotential surface can reduce the undulating field that occurs when separated contacts are used, such as found on traditional SCS-type leads that have spaced-apart contacts, as seen in FIGS. 4 and 5. FIG. 4 shows potential at various distances from a stimulation lead similar to the apparatus 300 having a single continuous flexible conductive surface that is 6 cm in length. FIG. 5 comparatively shows potential at various distances from a spinal cord stimulation lead having 6 mm contacts with 9 mm spacing. It can be seen that closer to the stimulation lead (for instance, at 2-mm and 4-mm distances), the potential of the single continuous flexible conductive surface lead (FIG. 4) is smoother than the potential of the spinal cord stimulation lead (FIG. 5). The smoother potential near the single continuous flexible conductive surface lead can reduce the likelihood that close neural structures are preferentially activated compared to further neural structures, ideally resulting in a broader area of activation.
  • Referring to FIG. 6, an apparatus 600 is configured for at least partial insertion in a living body. In some examples, the apparatus 600 is a stimulation lead for selective attachment to a stimulation device, such as, for instance, a microstimulator. Although described primarily herein with respect to stimulation leads, it should be understood that, in other examples, the apparatus can include other at least partially implantable devices.
  • In some examples, the apparatus 600 includes an elongate lead body 602 including a proximal lead end 602A′, 602A″ and a distal lead end 602B. In some examples, at least one connector 604′ is disposed proximate the proximal lead end 602A′. In some examples, the at least one connector 604′ includes a plug-like connector for engagement with the stimulation device. In other examples, the connector 604″ includes one or more contacts 605″ disposed in-line longitudinally along the lead body 602 proximate the proximal lead end 602A″ of the lead body 602. In some examples, the at least one connector 604′, 604″ is configured to electrically couple to the stimulation device. In some examples, a plurality of flexible conductive surfaces 610 is disposed at least partially around the lead body 602 proximate the distal lead end 602B. In some examples, the plurality of flexible conductive surfaces 610 is disposed completely around the lead body 602. The apparatus 600 further includes, in some examples, at least one conductor 606 extending within the lead body 602 from the at least one connector 604′, 604″ to the plurality of flexible conductive surfaces 610. In some examples, the at least one conductor 606 extends within a lumen 603 of the lead body 602.
  • In some examples, the apparatus 600 includes at least three flexible conductive surfaces including a center flexible conductive surface 610A including a first length, a distal flexible conductive surface 610B disposed distally on the elongate lead body 602 from the center flexible conductive surface 610A and including a second length, and a proximal flexible conductive surface 610C disposed proximally on the elongate lead body 602 from the center flexible conductive surface 610A and including a third length. In some examples, the second and third lengths of the being shorter than the first length. In some examples, the at least three flexible conductive surfaces 610A, 610B, 610C are longitudinally spaced along the elongate lead body 602 from one another. In some examples, the second length is substantially equal to the third length. In some examples, the first length is about 12-16 mm and the second length and the third length are each about 7-11 mm. In some examples, the flexible conductive surfaces 610 are longitudinally spaced along the lead body 602. In some examples, spacing between each of the flexible conductive surfaces 610 is substantially similar. In other examples, spacing between each of the flexible conductive surfaces 610 varies.
  • In some examples, the flexible conductive surfaces 610 have different lengths along the lead body 602. In the example shown in FIG. 6, the apparatus 600 includes seven flexible conductive surfaces 610, with the center flexible conductive surface 610A; three distal flexible conductive surfaces 610B, 610D, 610F disposed distally from the center conductive surface 610A; and three proximal flexible conductive surfaces 610C, 610E, 610G disposed proximally from the center conductive surface 610A, with the length of the center flexible conductive surface 610A being the longest and the lengths of the three distal flexible conductive surfaces 610B, 610D, 610F and the three proximal flexible conductive surfaces 610C, 610E, 610G getting shorter the farther from the center flexible conductive surface 610A they are. In some examples, a symmetrical pattern is used in which the largest flexible conductive surface 610A is positioned at the center of the contact array, for instance, approximately 12-16 mm in length; the next largest flexible conductive surfaces 610B, 610C flank the center flexible conductive surface 610A, one to each side and are longer, for instance, approximately 7-11 mm in length; the next smallest flexible conductive surfaces 610 D, 610E flank those outer contacts 610B, 610C, and are shorter in length than the outer contacts 610B, 610C; and so on. In some examples, this decreasing length-from-center pattern is continued for the desired full length of the conductor array along the lead body 602, for instance, approximately 6-20 cm in total.
  • In some examples, this decreasing length-from-center pattern is done to have the current density delivered from the lead be grossly-but-evenly distributed along the array length when connected to a simple single source (voltage or current) stimulation system. This allows for redistribution of current density “hot spots,” which occur near the edge of a single conductive surface, as seen in FIG. 7. If the flexible conductive surface is very long (for instance, the flexible conductive surface 310 of the lead body 302 of FIG. 7), then the resistive impedance is relatively low, and, with all the surface current leaving the edge of the contact, current density 311 will be relatively high toward the edges and relatively low therebetween. In some embodiments, the different length electrodes (for instance, the flexible conductive surfaces 610 of the lead body 602 of FIG. 7) will have different impedances and lead to more evenly distributed current density 611 along the length of the flexible conductive surfaces 610. This means that, for a fixed applied current or potential to all the flexible conductors, more of the current will be delivered from the center of the conductor array due to the lower impedance of the more central, longer contacts. This can reduce the only-at-the edge “hot spots” that might preferentially recruit Adelta or C fibers and thus limit the amount of current that can be comfortably delivered in PNFS. Since the goal in PNFS is to stimulate innocuous mechanoreceptor fibers (typically large Abeta fibers), having a broad, far-ranging mildly-changing-over-space electric field is considered advantageous.
  • In some examples, the apparatus 600 can include more or fewer than seven flexible conductive surfaces 610. In some examples, the apparatus 600 can include flexible conductive surfaces 610 of various lengths tailored to the particular application for which the apparatus 600 is being used. As such, it is contemplated in various examples, that the flexible conductive surfaces 610 can include any combination of lengths desired for peripheral nerve stimulation.
  • In some examples, each of the flexible conductive surfaces 610 includes a mesh. In some examples, each of the flexible conductive surfaces 610 is made of a metal mesh that envelopes the circumference of the lead body 602. In some embodiments, the mesh of each of the flexible conductive surfaces 610 can include a ‘rough’ surface that increases the geometric surface area of each of flexible conductive surfaces 610. In some instances, this increased geometric surface area can reduce the resistance while increasing the reactance of the effective electrode of each of the flexible conductive surfaces 610. By doing so, in some examples, the voltage to generate a specific current is reduced throughout the stimulation portion of the waveform, which can save battery power. In some examples, the mesh can include an arrangement of single crosshatched, braided, or otherwise disposed or applied conductors; an arrangement of multistranded crosshatched, braided, or otherwise disposed or applied conductors, and/or a variety of deposited thin film conductive elements, to name a few. In other examples, each of the flexible conductive surfaces can include a coil, for instance, similar to the at least one flexible conductive surface 210 described herein. In some examples, the coil can include an arrangement of single conductors; an arrangement of multistranded conductors, and/or a variety of deposited thin film conductive elements, to name a few.
  • Referring to FIG. 8, in some examples, a lead body 802 (which can be used in any of the apparatuses 100, 200, 300, 600 described herein) includes multiple lumens 803, 807. In some examples, the lead body 802 includes two or more conductors, wherein one of the conductors is disposed within a first lumen 807 of the lead body 802 and another of the conductors is disposed within a second lumen 807 of the lead body 802. In some examples, the lead body 802 includes multiple inner lumens 807 which allow multiple conductors to traverse the lead body 802 to their respective flexible conductive surfaces without abrasion against other conductors. In some examples, the lead body 802 includes a stylet lumen 803 configured to accept a stylet within the stylet lumen 803. In some examples, the lead body 802 includes a central lumen 803 to allow for a stylet to be passed through the lead body 802, which can be used to stiffen and/or curve the lead body 802, for instance, for tortuous or obstructed tissue pathways and/or to curve around tissue planes. In some examples, the lead body 802 including multiple lumens 803, 807 allows for improved handling and/or maneuverability of the lead body 802.
  • Referring to FIGS. 9A-9C, in some examples, stimulation systems 900A, 900B, 900C are shown in some exemplary implanted locations. It should be understood that these implant locations are merely exemplary and that it is contemplated that the stimulation systems 940A, 940B, 940C can be implanted in various other locations of the body that are not specifically shown herein. In some examples, one or more stimulation leads 900A, 900B, 900C with flexible conductive surfaces (similar to any of the apparatuses 100, 200, 300, 600 described herein) are connected to a microstimulator 950A, 950B, 950C. In some examples, the microstimulators 950A, 950B, 950C are present on the same body segment as the respective one or more stimulation leads 900A, 900B, 900C. In this way, by not traversing a joint with the stimulation leads 900A, 900B, 900C, the chances of any one or more of lead damage, lead dislodgment, lead migration, skin erosion, lead-stimulator uncoupling, and lead fatigue are decreased. Some examples of the body segments include: a thigh 10 (FIG. 9A), a calf/shin, a forearm, an upper arm 20 (FIG. 9B), a neck 30 (FIG. 9C), a head, a foot, a hand, or the like, to name a few. In each segment 10, 20, 30, the stimulation system 940A, 940B, 940C includes stimulation leads 900A, 900B, 900C that are of appropriate length to allow for placement within or nearby the therapy target, some looping to inhibit tension from creating migration of the stimulation lead 900A, 900B, 900C, and/or connection to the microstimulator 950A, 950B, 950C, all implanted within that body segment 10, 20, 30.
  • It is noted that, while the present figures portray example leads with flexible conductive surfaces having a greater diameter than the respective lead bodies, in other examples, it is contemplated that the flexible conductive surfaces have substantially the same diameter as the respective lead bodies, making the leads isodiametric.
  • In some examples, the lead (for instance, any of the apparatuses 100, 200, 300, 600, 900A, 900B, 900C) has a relative small diameter, ranging between about 0.1 mm and about 1 mm. In some examples, this allows for better ability to place and position the lead over areas with thin regions of soft tissue, such as the skull, for instance, improving cosmesis as well as reducing the likelihood of erosion. In some embodiments, the lead body 102, 202, 302, 602 is made of a biocompatible polymer, which is flexible and durable within the body. In some examples, this can be advantageous for extremities, which are typically in motion and undergo shape changes and make frequent contact with the outside world during activities of daily living.
  • In various examples described herein, it is contemplated that peripheral nerves may be directly targeted to mitigate chronic pain of limbs, for instance. The various flexible conductive surfaces 110, 210, 310, 610 described herein allow for increased flexibility of the respective lead bodies 102, 202, 302, 602, allowing for better body conformance, increased comfort, decreased skin erosion, and the like. Additionally, the various flexible conductive surfaces 110, 210, 310, 610 described herein allow for increased contact, leading to more effective and efficient use of power, which, in some examples, can be advantageous due to the desired smaller size of components. In some examples, the various flexible conductive surfaces 110, 210, 310, 610 described herein allow for stimulation of a relatively wide area with relatively low power needed to do so.
  • The present inventor has recognized various advantages of the subject matter described herein. For instance, in some examples, the apparatuses, systems, and methods described herein can be used to better provide PNFS using one or more flexible conductive surfaces. In various examples, the apparatuses, systems, and methods described herein are considered advantageous in that they allow for generation of a broad field to provide better PNFS. Additionally, in various examples, the apparatuses, systems, and methods described herein include PNFS apparatuses, systems, and methods sized, shaped, or otherwise configured for placement in patient extremities or other body segments. While various advantages of the example apparatuses, systems, and methods are listed herein, this list is not considered to be complete, as further advantages may become apparent from the description and figures presented herein.
  • Although the subject matter of the present patent application has been described with reference to various examples, workers skilled in the art will recognize that changes can be made in form and detail without departing from the scope of the subject matter recited in the below claims.
  • The above Detailed Description includes references to the accompanying drawings, which form a part of the Detailed Description. The drawings show, by way of illustration, specific examples in which the present apparatuses and methods can be practiced. These embodiments are also referred to herein as “examples.”
  • The above Detailed Description is intended to be illustrative, and not restrictive. For example, the above-described examples (or one or more elements thereof) can be used in combination with each other. Other embodiments can be used, such as by one of ordinary skill in the art upon reviewing the above description. Also, various features or elements can be grouped together to streamline the disclosure. This should not be interpreted as intending that an unclaimed disclosed feature is essential to any claim. Rather, inventive subject matter can lie in less than all features of a particular disclosed embodiment. Thus, the following claims are hereby incorporated into the Detailed Description, with each claim standing on its own as a separate embodiment. The scope of the invention should be determined with reference to the appended claims, along with the full scope of equivalents to which such claims are entitled.
  • In this document, the terms “a” or “an” are used to include one or more than one, independent of any other instances or usages of “at least one” or “one or more.” In this document, the term “or” is used to refer to a nonexclusive or, such that “A or B” includes “A but not B,” “B but not A,” and “A and B,” unless otherwise indicated. In this document, the terms “about” and “approximately” or similar are used to refer to an amount that is nearly, almost, or in the vicinity of being equal to a stated amount.
  • In the appended claims, the terms “including” and “in which” are used as the plain-English equivalents of the respective terms “comprising” and “wherein.” Also, in the following claims, the terms “including” and “comprising” are open-ended, that is, an apparatus or method that includes elements in addition to those listed after such a term in a claim are still deemed to fall within the scope of that claim. Moreover, in the following claims, the terms “first,” “second,” and “third,” etc. are used merely as labels, and are not intended to impose numerical requirements on their objects.
  • The Abstract is provided to allow the reader to quickly ascertain the nature of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims.

Claims (20)

1. An apparatus configured for at least partial insertion in a living body, the apparatus comprising:
an elongate lead body including a proximal lead end and a distal lead end;
at least one connector disposed proximate the proximal lead end;
at least one flexible conductive surface disposed at least partially around the lead body proximate the distal lead end; and
at least one conductor extending within the lead body from the at least one connector to the at least one flexible conductive surface.
2. The apparatus of claim 1, wherein the at least one flexible conductive surface includes a mesh.
3. The apparatus of claim 1, wherein the at least one flexible conductive surface includes a coil.
4. The apparatus of claim 1, wherein the at least one flexible conductive surface is disposed completely around the lead body.
5. The apparatus of claim 1, wherein the at least one flexible conductive surface includes a length between 1 cm and 20 cm.
6. The apparatus of claim 1, wherein the at least one flexible conductive surface includes two or more flexible conductive surfaces.
7. The apparatus of claim 6, wherein the two or more flexible conductive surfaces includes at least three flexible conductive surfaces, wherein:
a center flexible conductive surface includes a first length;
a distal flexible conductive surface disposed distally on the elongate lead body from the center flexible conductive surface and including a second length; and
a proximal flexible conductive surface disposed proximally on the elongate lead body from the center flexible conductive surface and including a third length, the second and third lengths being shorter than the first length.
8. The apparatus of claim 7, wherein the at least three flexible conductive surfaces are longitudinally spaced along the elongate lead body from one another.
9. The apparatus of claim 7, wherein the second length is substantially equal to the third length.
10. The apparatus of claim 7, wherein the first length is 12-16 mm and the second length and the third length are each 7-11 mm.
11. The apparatus of claim 1, wherein the at least one conductor extends within a lumen of the lead body.
12. The apparatus of claim 1, wherein the at least one conductor includes two or more conductors, wherein one of the conductors is disposed within a first lumen of the lead body and another of the conductors is disposed within a second lumen of the lead body.
13. The apparatus of claim 12, wherein the lead body includes a stylet lumen configured to accept a stylet within the stylet lumen.
14. An apparatus configured for at least partial insertion in a living body, the apparatus comprising:
an elongate lead body including a proximal lead end, a distal lead end, and a lumen within the lead body;
a connector disposed proximate the proximal lead end;
a flexible conductive surface disposed at least partially around the lead body proximate the distal lead end; and
a conductor extending within the lumen, the conductor extending from the connector to the flexible conductive surface.
15. The apparatus of claim 14, wherein the flexible conductive surface includes a mesh.
16. The apparatus of claim 14, wherein the flexible conductive surface includes a coil.
17. The apparatus of claim 14, comprising at least a second flexible conductive surface disposed at least partially around the lead body proximate the distal lead end.
18. An apparatus configured for at least partial insertion in a living body, the apparatus comprising:
an elongate lead body including a proximal lead end, a distal lead end, and at least one lumen within the lead body;
at least one connector disposed proximate the proximal lead end;
at least one flexible conductive surface disposed around the lead body proximate the distal lead end;
at least one conductor extending within the at least one lumen, the at least one conductor extending from the at least one connector to the at least one flexible conductive surface; and
a stylet lumen disposed within the lead body, the stylet lumen configured to accept a stylet within the stylet lumen.
19. The apparatus of claim 18, wherein the flexible conductive surface includes a mesh.
20. The apparatus of claim 18, wherein the flexible conductive surface includes a coil.
US14/317,948 2013-07-02 2014-06-27 Apparatus, system, and method for minimized energy in peripheral field stimulation Abandoned US20150018911A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/317,948 US20150018911A1 (en) 2013-07-02 2014-06-27 Apparatus, system, and method for minimized energy in peripheral field stimulation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361841965P 2013-07-02 2013-07-02
US14/317,948 US20150018911A1 (en) 2013-07-02 2014-06-27 Apparatus, system, and method for minimized energy in peripheral field stimulation

Publications (1)

Publication Number Publication Date
US20150018911A1 true US20150018911A1 (en) 2015-01-15

Family

ID=52133275

Family Applications (17)

Application Number Title Priority Date Filing Date
US14/316,960 Active US9539422B2 (en) 2013-07-02 2014-06-27 Neurostimulator interconnection apparatus, system, and method
US14/317,948 Abandoned US20150018911A1 (en) 2013-07-02 2014-06-27 Apparatus, system, and method for minimized energy in peripheral field stimulation
US14/319,714 Active 2035-06-13 US9750930B2 (en) 2013-07-02 2014-06-30 Circuit for discriminating between battery charging signals and RF telemetry signals received by a single coil in an implantable medical device
US14/321,234 Active 2035-06-12 US9744347B2 (en) 2013-07-02 2014-07-01 Systems and methods for reducing power consumption in an implantable medical device
US14/320,898 Active 2038-01-04 US11135424B2 (en) 2013-07-02 2014-07-01 Apparatus, system, and method for targeted placement of a percutaneous electrode
US14/320,676 Expired - Fee Related US9227052B2 (en) 2013-07-02 2014-07-01 Neurostimulator interconnection apparatus, system, and method
US14/322,455 Active US9295832B2 (en) 2013-07-02 2014-07-02 Paddle lead maximizing lateral target points across a peripheral nerve
US14/321,914 Expired - Fee Related US9415211B2 (en) 2013-07-02 2014-07-02 System and method for selective and maintained activation of sensory peripheral nerve fibers
US14/322,172 Active 2035-08-01 US9764128B2 (en) 2013-07-02 2014-07-02 System and method for improving nerve finding for peripheral nerve stimulation
US14/322,394 Active 2035-05-29 US9731116B2 (en) 2013-07-02 2014-07-02 Charge pump system, devices and methods for an implantable stimulator
US14/322,716 Expired - Fee Related US9248279B2 (en) 2013-07-02 2014-07-02 Neurostimulator configured to sense evoked potentials in peripheral nerves
US15/001,327 Expired - Fee Related US9526897B2 (en) 2013-07-02 2016-01-20 Neurostimulator configured to sense evoked potentials in peripheral nerves
US15/180,613 Expired - Fee Related US9636497B2 (en) 2013-07-02 2016-06-13 System and method for selective and maintained activation of sensory peripheral nerve fibers
US15/355,117 Expired - Fee Related US10376688B2 (en) 2013-07-02 2016-11-18 Neurostimulator interconnection apparatus, system, and method
US15/583,249 Active 2034-07-10 US10384054B2 (en) 2013-07-02 2017-05-01 Charge pump system, devices and methods for an implantable stimulator
US15/594,841 Active 2034-09-10 US10456574B2 (en) 2013-07-02 2017-05-15 Systems and methods for reducing power consumption in an implantable medical device
US15/657,968 Active 2034-07-13 US10463852B2 (en) 2013-07-02 2017-07-24 System and method for improving nerve finding for peripheral nerve stimulation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US14/316,960 Active US9539422B2 (en) 2013-07-02 2014-06-27 Neurostimulator interconnection apparatus, system, and method

Family Applications After (15)

Application Number Title Priority Date Filing Date
US14/319,714 Active 2035-06-13 US9750930B2 (en) 2013-07-02 2014-06-30 Circuit for discriminating between battery charging signals and RF telemetry signals received by a single coil in an implantable medical device
US14/321,234 Active 2035-06-12 US9744347B2 (en) 2013-07-02 2014-07-01 Systems and methods for reducing power consumption in an implantable medical device
US14/320,898 Active 2038-01-04 US11135424B2 (en) 2013-07-02 2014-07-01 Apparatus, system, and method for targeted placement of a percutaneous electrode
US14/320,676 Expired - Fee Related US9227052B2 (en) 2013-07-02 2014-07-01 Neurostimulator interconnection apparatus, system, and method
US14/322,455 Active US9295832B2 (en) 2013-07-02 2014-07-02 Paddle lead maximizing lateral target points across a peripheral nerve
US14/321,914 Expired - Fee Related US9415211B2 (en) 2013-07-02 2014-07-02 System and method for selective and maintained activation of sensory peripheral nerve fibers
US14/322,172 Active 2035-08-01 US9764128B2 (en) 2013-07-02 2014-07-02 System and method for improving nerve finding for peripheral nerve stimulation
US14/322,394 Active 2035-05-29 US9731116B2 (en) 2013-07-02 2014-07-02 Charge pump system, devices and methods for an implantable stimulator
US14/322,716 Expired - Fee Related US9248279B2 (en) 2013-07-02 2014-07-02 Neurostimulator configured to sense evoked potentials in peripheral nerves
US15/001,327 Expired - Fee Related US9526897B2 (en) 2013-07-02 2016-01-20 Neurostimulator configured to sense evoked potentials in peripheral nerves
US15/180,613 Expired - Fee Related US9636497B2 (en) 2013-07-02 2016-06-13 System and method for selective and maintained activation of sensory peripheral nerve fibers
US15/355,117 Expired - Fee Related US10376688B2 (en) 2013-07-02 2016-11-18 Neurostimulator interconnection apparatus, system, and method
US15/583,249 Active 2034-07-10 US10384054B2 (en) 2013-07-02 2017-05-01 Charge pump system, devices and methods for an implantable stimulator
US15/594,841 Active 2034-09-10 US10456574B2 (en) 2013-07-02 2017-05-15 Systems and methods for reducing power consumption in an implantable medical device
US15/657,968 Active 2034-07-13 US10463852B2 (en) 2013-07-02 2017-07-24 System and method for improving nerve finding for peripheral nerve stimulation

Country Status (1)

Country Link
US (17) US9539422B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210265922A1 (en) * 2020-02-20 2021-08-26 Toyota Jidosha Kabushiki Kaisha Actuator and actuator manufacturing method

Families Citing this family (152)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9265431B2 (en) 2010-06-18 2016-02-23 Cardiac Pacemakers, Inc. Methods and apparatus for controlling neurostimulation using evoked physiologic events
US10758723B2 (en) 2011-05-19 2020-09-01 Neuros Medical, Inc. Nerve cuff electrode for neuromodulation in large human nerve trunks
US11413458B2 (en) 2011-05-19 2022-08-16 Neuros Medical, Inc. Nerve cuff electrode for neuromodulation in large human nerve trunks
US11211741B2 (en) 2011-06-03 2021-12-28 Greatbatch Ltd. Removable terminal pin connector for an active electronics circuit board for use in an implantable medical device
ES2649984T3 (en) 2011-11-15 2018-01-16 Neurometrix, Inc. Apparatus for relieving pain using transcutaneous electrical nerve stimulation
WO2013111137A2 (en) 2012-01-26 2013-08-01 Rainbow Medical Ltd. Wireless neurqstimulatqrs
WO2014063163A1 (en) 2012-10-19 2014-04-24 Block Jonathan D Systems and methods for nerve mapping and monitoring
US10485972B2 (en) 2015-02-27 2019-11-26 Thync Global, Inc. Apparatuses and methods for neuromodulation
US11033731B2 (en) 2015-05-29 2021-06-15 Thync Global, Inc. Methods and apparatuses for transdermal electrical stimulation
US10814131B2 (en) 2012-11-26 2020-10-27 Thync Global, Inc. Apparatuses and methods for neuromodulation
US10537703B2 (en) 2012-11-26 2020-01-21 Thync Global, Inc. Systems and methods for transdermal electrical stimulation to improve sleep
WO2014087337A1 (en) 2012-12-06 2014-06-12 Bluewind Medical Ltd. Delivery of implantable neurostimulators
CN108355242B (en) 2013-01-21 2022-04-15 卡拉健康公司 Apparatus and method for controlling tremor
CN105164920B (en) 2013-03-15 2018-02-06 艾尔弗雷德·E·曼科学研究基金会 Current sense multi-output current stimulator with fast on-times
US10940311B2 (en) * 2013-03-29 2021-03-09 Neurometrix, Inc. Apparatus and method for button-free control of a wearable transcutaneous electrical nerve stimulator using interactive gestures and other means
US10293161B2 (en) 2013-06-29 2019-05-21 Thync Global, Inc. Apparatuses and methods for transdermal electrical stimulation of nerves to modify or induce a cognitive state
US9539422B2 (en) * 2013-07-02 2017-01-10 Greatbatch Ltd. Neurostimulator interconnection apparatus, system, and method
CN105407964B (en) 2013-07-26 2018-05-04 波士顿科学神经调制公司 The system that modulation therapy and unaware are provided
CA3075310C (en) 2013-07-29 2022-04-05 Alfred E. Mann Foundation For Scientific Research Microprocessor controlled class e driver
DE102013216753A1 (en) * 2013-08-23 2015-02-26 Novero Dabendorf Gmbh Device and method for combined signal transmission or for combined signal and energy transmission
CN105682733B (en) 2013-10-30 2017-12-05 波士顿科学神经调制公司 For the part control for avoiding Dorsal root from stimulating
WO2015131093A1 (en) 2014-02-27 2015-09-03 Thync, Inc. Methods and apparatuses for user control of neurostimulation
CN106413805A (en) 2014-06-02 2017-02-15 卡拉健康公司 Systems and methods for peripheral nerve stimulation to treat tremor
WO2016025910A1 (en) 2014-08-15 2016-02-18 Axonics Modulation Technologies, Inc. Implantable lead affixation structure for nerve stimulation to alleviate bladder dysfunction and other indications
CA2958199C (en) 2014-08-15 2023-03-07 Axonics Modulation Technologies, Inc. Electromyographic lead positioning and stimulation titration in a nerve stimulation system for treatment of overactive bladder
JP6779860B2 (en) 2014-08-15 2020-11-04 アクソニクス モジュレーション テクノロジーズ インコーポレイテッド Integrated EMG clinician programming device for use with implantable neurostimulators
EP3180073B1 (en) 2014-08-15 2020-03-11 Axonics Modulation Technologies, Inc. System for neurostimulation electrode configurations based on neural localization
EP3180071B1 (en) 2014-08-15 2021-09-22 Axonics, Inc. External pulse generator device and associated system for trial nerve stimulation
KR20170047300A (en) 2014-08-26 2017-05-04 아벤트, 인크. Selective nerve fiber block method and system
US11534608B2 (en) 2015-01-04 2022-12-27 Ist, Llc Methods and apparatuses for transdermal stimulation of the outer ear
US10426945B2 (en) 2015-01-04 2019-10-01 Thync Global, Inc. Methods and apparatuses for transdermal stimulation of the outer ear
EP3242721B1 (en) 2015-01-09 2019-09-18 Axonics Modulation Technologies, Inc. Attachment devices and associated methods of use with a nerve stimulation charging device
CN107427683B (en) 2015-01-09 2019-06-21 艾克索尼克斯调制技术股份有限公司 For can plant the improvement antenna and application method of nerve stimulator
JP6805153B2 (en) 2015-01-09 2020-12-23 アクソニクス モジュレーション テクノロジーズ インコーポレイテッド How to use with patient remote devices and associated neurostimulation systems
PL3244965T3 (en) 2015-01-13 2023-07-24 Theranica Bio-Electronics Ltd. Treatment of headaches by electrical stimulation
US10004896B2 (en) 2015-01-21 2018-06-26 Bluewind Medical Ltd. Anchors and implant devices
US9782589B2 (en) 2015-06-10 2017-10-10 Bluewind Medical Ltd. Implantable electrostimulator for improving blood flow
CN112914514A (en) 2015-06-10 2021-06-08 卡拉健康公司 System and method for peripheral nerve stimulation to treat tremor with a detachable treatment and monitoring unit
JP6946261B2 (en) 2015-07-10 2021-10-06 アクソニクス インコーポレイテッド Implantable nerve stimulators and methods with internal electronics without ASICs
WO2017044904A1 (en) * 2015-09-11 2017-03-16 Nalu Medical, Inc. Apparatus for peripheral or spinal stimulation
US10603482B2 (en) 2015-09-23 2020-03-31 Cala Health, Inc. Systems and methods for peripheral nerve stimulation in the finger or hand to treat hand tremors
US10105540B2 (en) 2015-11-09 2018-10-23 Bluewind Medical Ltd. Optimization of application of current
US9713707B2 (en) 2015-11-12 2017-07-25 Bluewind Medical Ltd. Inhibition of implant migration
EP3377136B1 (en) * 2015-11-20 2020-05-06 Tc1 Llc Energy management of blood pump controllers
WO2017106411A1 (en) 2015-12-15 2017-06-22 Cerevast Medical, Inc. Electrodes having surface exclusions
US10864373B2 (en) * 2015-12-15 2020-12-15 Case Western Reserve University Systems for treatment of a neurological disorder using electrical nerve conduction block
WO2017106878A1 (en) 2015-12-18 2017-06-22 Thync Global, Inc. Apparatuses and methods for transdermal electrical stimulation of nerves to modify or induce a cognitive state
US9956405B2 (en) 2015-12-18 2018-05-01 Thyne Global, Inc. Transdermal electrical stimulation at the neck to induce neuromodulation
CA3011993A1 (en) 2016-01-21 2017-08-03 Cala Health, Inc. Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder
EP3407965B1 (en) 2016-01-29 2021-03-03 Axonics Modulation Technologies, Inc. Systems for frequency adjustment to optimize charging of implantable neurostimulator
KR101747023B1 (en) * 2016-02-11 2017-06-14 인하대학교 산학협력단 Low-power Neuromodulator and operating method thereof
JP7072510B2 (en) * 2016-02-12 2022-05-20 アクソニクス インコーポレイテッド External pulse generator devices and related methods for experimental nerve stimulation
US20170259072A1 (en) * 2016-03-14 2017-09-14 Qualcomm Incorporated System architecture for medical implant
US10376702B2 (en) 2016-04-04 2019-08-13 Boston Scientific Neuromodulation Corporation System to estimate the location of a spinal cord physiological midline
US10149979B2 (en) 2016-04-04 2018-12-11 Boston Scientific Neuromodulation Corporation System to estimate the location of a spinal cord physiological midline
US10406368B2 (en) 2016-04-19 2019-09-10 Boston Scientific Neuromodulation Corporation Pulse generator system for promoting desynchronized firing of recruited neural populations
EP3238778B1 (en) * 2016-04-26 2019-06-12 BIOTRONIK SE & Co. KG Header for a medical implant device, particularly for a pacemaker
KR101731211B1 (en) 2016-05-12 2017-04-28 (주)나눔테크 Low Power Type Pacemaker
US10646708B2 (en) 2016-05-20 2020-05-12 Thync Global, Inc. Transdermal electrical stimulation at the neck
CN109475295B (en) * 2016-06-29 2022-07-26 皇家飞利浦有限公司 Methods and devices for health devices and wearable/implantable devices
AU2017293799B2 (en) 2016-07-08 2022-10-20 Cala Health, Inc. Systems and methods for stimulating n nerves with exactly n electrodes and improved dry electrodes
US11272871B2 (en) 2016-07-14 2022-03-15 Sidewaystrategies Llc System and methods for improving diagnostic evoked potential studies for functional assessments of nerves and nerve pathways
AU2017315764B2 (en) * 2016-08-25 2022-11-10 Cala Health, Inc. Systems and methods for treating cardiac dysfunction through peripheral nerve stimulation
US10632300B2 (en) * 2016-09-10 2020-04-28 Boston Scientific Neuromodulation Corporation Measurement circuitry for measuring analog values in an implantable pulse generator
US11357980B2 (en) 2016-09-29 2022-06-14 Theranica Bio-Electronics Ltd. Apparatus for applying an electrical signal to a subject
EP3532151A1 (en) 2016-10-28 2019-09-04 Medtronic, Inc. Controlling electrical stimulation therapy
US10124178B2 (en) 2016-11-23 2018-11-13 Bluewind Medical Ltd. Implant and delivery tool therefor
US10792495B2 (en) 2016-12-01 2020-10-06 Thimble Bioelectronics, Inc. Neuromodulation device and method for use
CN106816923A (en) * 2016-12-26 2017-06-09 广东欧珀移动通信有限公司 A kind of wireless original-pack adapter knows method for distinguishing and terminal
US11766559B2 (en) 2017-01-18 2023-09-26 Soin Neuroscience, LLC Tunable electrical noise signal technologies
KR102170003B1 (en) * 2017-01-18 2020-10-26 소인 뉴로사이언스 인코포레이티드 Method and system for providing treatment to a patient through the application of a wide spectrum of adjustable electrical noise signals
US11925805B2 (en) 2017-01-18 2024-03-12 Soin Neuroscience, LLC Tunable electrical noise signal technologies
US11040209B2 (en) 2017-01-19 2021-06-22 Boston Scienitific Neuromodulation Corporation Radio frequency antenna capacitively coupled to a charging coil in an implantable medical device
US10420930B2 (en) * 2017-02-13 2019-09-24 Pacesetter, Inc. Paddle lead with elastic deflection coupling between feed wire and paddle
US20180272134A1 (en) * 2017-03-21 2018-09-27 Boston Scientific Neuromodulation Corporation Microstimulator Having Body-Mounted Electrodes and Remote Electrode Leads
CN110809486A (en) 2017-04-03 2020-02-18 卡拉健康公司 Peripheral neuromodulation systems, methods, and devices for treating diseases associated with overactive bladder
US11167135B2 (en) 2017-05-21 2021-11-09 Theranica Bio-Electronics Ltd. Apparatus for providing pain relief therapy
US20180353764A1 (en) 2017-06-13 2018-12-13 Bluewind Medical Ltd. Antenna configuration
US11612751B2 (en) 2017-08-11 2023-03-28 Boston Scientific Neuromodulation Corporation Stimulation configuration variation to control evoked temporal patterns
WO2019021754A1 (en) * 2017-09-21 2019-01-31 大塚テクノ株式会社 Electrical stimulation therapy instrument
US11318297B2 (en) * 2017-09-21 2022-05-03 Medtronic, Inc. Imaging markers for stimulator leads
KR102495358B1 (en) * 2017-09-25 2023-02-02 삼성전자주식회사 Neuromimetic stimulating apparatus and method thereof
US11575281B2 (en) 2017-09-26 2023-02-07 Stryker Corporation System and method for wirelessly charging a medical device battery
EP3691744B1 (en) 2017-10-04 2021-07-28 Boston Scientific Neuromodulation Corporation Adjustment of stimulation in a stimulator using detected evoked compound action potentials
WO2019094109A1 (en) 2017-11-08 2019-05-16 Boston Scientific Neuromodulation Corporation System to improve a spinal cord stimulation model based on physiological midline location
DE17201800T1 (en) 2017-11-15 2019-09-26 Gtx Medical B.V. MEDICAL COMMUNICATION AND CHARGING SYSTEM
EP3487005A1 (en) * 2017-11-21 2019-05-22 BIOTRONIK SE & Co. KG Clip for making a mechanical and electrically conductive connection between the clip and a pin, especially a feedthrough pin
JP7279048B2 (en) 2017-12-13 2023-05-22 ニューロス・メディカル・インコーポレイティッド Nerve cuff deployment device
WO2019136072A1 (en) 2018-01-08 2019-07-11 Boston Scientific Neuromodulation Corporation Automatic adjustment of sub-perception therapy in an implantable stimulator using detected compound action potentials
US11857778B2 (en) 2018-01-17 2024-01-02 Cala Health, Inc. Systems and methods for treating inflammatory bowel disease through peripheral nerve stimulation
AU2019217416B2 (en) 2018-02-09 2021-06-24 Boston Scientific Neuromodulation Corporation Systems and methods for determining neuromodulation parameters
EP3755418B1 (en) 2018-02-22 2023-06-21 Axonics, Inc. Neurostimulation leads for trial nerve stimulation
TWI712432B (en) * 2018-03-05 2020-12-11 鄭惇方 Bio-energy signal capture and conversion device
EP3536374B1 (en) 2018-03-05 2022-06-29 Boston Scientific Neuromodulation Corporation Virtual target pole adjustment based on nerve root trajectory
EP3765145A1 (en) 2018-03-12 2021-01-20 Boston Scientific Neuromodulation Corporation Neural stimulation with decomposition of evoked compound action potentials
US20190282799A1 (en) 2018-03-15 2019-09-19 Avent, Inc. Percutaneous lead
US10974042B2 (en) 2018-03-26 2021-04-13 Boston Scientific Neuromodulation Corporation System and methods for heart rate and electrocardiogram extraction from a spinal cord stimulation system
EP4218912A1 (en) 2018-03-27 2023-08-02 Boston Scientific Neuromodulation Corporation Hybrid sensing and stimulation utilizing pre-pulsing of waveforms
US11040202B2 (en) 2018-03-30 2021-06-22 Boston Scientific Neuromodulation Corporation Circuitry to assist with neural sensing in an implantable stimulator device
BR112020020867A2 (en) * 2018-04-09 2021-01-26 Neuros Medical, Inc. apparatus and methods for adjusting electrical dose
US11278724B2 (en) 2018-04-24 2022-03-22 Thync Global, Inc. Streamlined and pre-set neuromodulators
AU2019260567B2 (en) 2018-04-27 2021-09-23 Boston Scientific Neuromodulation Corporation Neurostimulation system for delivering selectivity modes
EP3574952B1 (en) * 2018-05-30 2020-11-25 G-Therapeutics BV An electrode array, a lead paddle and a neuromodulation system
EP3799576B1 (en) 2018-06-01 2024-04-10 Boston Scientific Neuromodulation Corporation Artifact reduction in a sensed neural response
US11129991B2 (en) 2018-06-21 2021-09-28 Medtronic, Inc. ECAP based control of electrical stimulation therapy
EP3626305A1 (en) 2018-09-21 2020-03-25 BIOTRONIK SE & Co. KG Electrical arrangement for inductive charging and wireless communication
DE18205817T1 (en) 2018-11-13 2020-12-24 Gtx Medical B.V. SENSOR IN CLOTHING OF LIMBS OR FOOTWEAR
CN113015552A (en) * 2018-11-16 2021-06-22 威里利生命科学有限责任公司 Branch proximal connector for high density neural interface
US11883661B2 (en) 2018-12-07 2024-01-30 Neurometrix, Inc. Intelligent determination of therapeutic stimulation intensity for transcutaneous electrical nerve stimulation
US11413457B2 (en) 2019-01-22 2022-08-16 Boston Scientific Neuromodulation Corporation Fitting algorithm for recruiting of neural targets in a spinal cord stimulator system
EP3693055B1 (en) 2019-02-09 2022-05-11 ONWARD Medical N.V. Wireless power transfer for medical devices
WO2020168136A1 (en) 2019-02-13 2020-08-20 Avent, Inc Portable electrical stimulation system and method
DE102019214752B4 (en) 2019-09-26 2022-12-15 CereGate GmbH NEURAL SIGNALING SYSTEM, METHOD AND COMPUTER PROGRAM FOR SIGNALING A DEVICE CONDITION
DE102019202666B4 (en) 2019-02-27 2021-04-29 CereGate GmbH Neural communication system
DE102019209096B4 (en) 2019-06-24 2022-12-15 CereGate GmbH NEURAL SIGNALING SYSTEM FOR BEHAVIOR MODIFICATION
WO2020185902A1 (en) 2019-03-11 2020-09-17 Axonics Modulation Technologies, Inc. Charging device with off-center coil
CA3128134A1 (en) 2019-03-29 2020-10-08 Boston Scientific Neuromodulation Corporation Neural sensing in an implantable stimulator device during the provision of active stimulation
EP4218902A1 (en) 2019-03-29 2023-08-02 Boston Scientific Neuromodulation Corporation Circuitry to assist with neural sensing in an implantable stimulator device in the presence of stimulation artifacts
US11357990B2 (en) * 2019-04-05 2022-06-14 Biotronik Se & Co. Kg Method for programming an implantable medical device and system for configuring stimulation parameters of an implantable medical device
US11090503B2 (en) 2019-04-14 2021-08-17 Gary L. Bush Nuclear quadrupole applications for enhanced nerve ion function
US11273313B2 (en) * 2019-04-18 2022-03-15 Boston Scientific Neuromodulation Corporation Dynamic visualization of neuronal sub population interactions
US11738198B2 (en) 2019-05-10 2023-08-29 The Freestate Of Bavaria Represented By The Julius Maximilians-Universität Würzbrg System to optimize anodic stimulation modes
US11848090B2 (en) 2019-05-24 2023-12-19 Axonics, Inc. Trainer for a neurostimulator programmer and associated methods of use with a neurostimulation system
US11439829B2 (en) 2019-05-24 2022-09-13 Axonics, Inc. Clinician programmer methods and systems for maintaining target operating temperatures
US11504526B2 (en) 2019-05-30 2022-11-22 Boston Scientific Neuromodulation Corporation Methods and systems for discrete measurement of electrical characteristics
EP3747504A1 (en) 2019-06-05 2020-12-09 GTX medical B.V. Antenna for an implantable pulse generator
US11623095B2 (en) 2019-06-20 2023-04-11 Boston Scientific Neuromodulation Corporation Methods and systems for interleaving waveforms for electrical stimulation and measurement
US11890468B1 (en) 2019-10-03 2024-02-06 Cala Health, Inc. Neurostimulation systems with event pattern detection and classification
US11679256B2 (en) 2019-10-04 2023-06-20 Medtronic, Inc. Method of replacing an implanted neuromodulation device
US11596789B2 (en) 2019-10-04 2023-03-07 Medtronic, Inc. Adaptor
US11575236B2 (en) * 2019-10-04 2023-02-07 Medtronic, Inc. Implantable pulse generator carrier used to interface with multiple lead sizes
US11931582B2 (en) 2019-10-25 2024-03-19 Medtronic, Inc. Managing transient overstimulation based on ECAPs
US11547855B2 (en) 2019-10-25 2023-01-10 Medtronic, Inc. ECAP sensing for high frequency neurostimulation
CA3160654A1 (en) * 2019-11-08 2021-05-14 Synchron Australia Pty Limited Methods, systems, and apparatus for closed-loop neuromodulation
AU2021219722A1 (en) 2020-02-11 2022-09-08 Neuros Medical, Inc. System and method for quantifying qualitative patient-reported data sets
US11666768B2 (en) 2020-03-04 2023-06-06 Medtronic, Inc. Electrically isolated connector for implantable medical devices
US20210387002A1 (en) * 2020-06-10 2021-12-16 Medtronic, Inc. Control policy settings for electrical stimulation therapy
US11857793B2 (en) 2020-06-10 2024-01-02 Medtronic, Inc. Managing storage of sensed information
DE102020210676A1 (en) 2020-08-21 2022-02-24 CereGate GmbH CLOSED-LOOP COMPUTER-BRAIN INTERFACE DEVICE
US11707626B2 (en) 2020-09-02 2023-07-25 Medtronic, Inc. Analyzing ECAP signals
US11547860B2 (en) * 2020-09-30 2023-01-10 Medtronic, Inc. Closed-loop therapy stimulation response to patient adjustment
US11648402B2 (en) 2020-09-30 2023-05-16 Medtronic, Inc. Lead integrity and closed-loop algorithm diagnostic
US11559689B2 (en) 2020-09-30 2023-01-24 Medtronic, Inc. Noise detection and modulation of closed-loop therapy action
US11583682B2 (en) * 2020-12-07 2023-02-21 Onward Medical N.V. Antenna for an implantable pulse generator
WO2022198171A1 (en) 2021-03-18 2022-09-22 Boston Scientific Neuromodulation Corporation Methods and systems for target localization and dbs therapy
US11621515B2 (en) 2021-03-25 2023-04-04 Neuropace, Inc. Connector assembly for active implantable medical device
WO2022214600A1 (en) 2021-04-07 2022-10-13 CereGate GmbH Closed-loop autocalibration method for a computer brain interface device, computer program and computer brain interface device
US20220323763A1 (en) 2021-04-07 2022-10-13 CereGate GmbH On-line autocalibration method for a computer brain interface device and computer brain interface device
US11400299B1 (en) 2021-09-14 2022-08-02 Rainbow Medical Ltd. Flexible antenna for stimulator
US20230131115A1 (en) * 2021-10-21 2023-04-27 GE Precision Healthcare LLC System and Method for Displaying Position of Echogenic Needles
US11793443B2 (en) 2022-02-01 2023-10-24 Soin Neuroscience, LLC Adjustable random electrical stimulation technologies
US20230414953A1 (en) * 2022-06-28 2023-12-28 Medtronic, Inc. Coordinating use of power-saving battery switch hardware feature by multiple firmware features

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6119044A (en) * 1997-06-02 2000-09-12 Advanced Bionics Corporation Cochlear electrode array with positioning stylet
US20080188917A1 (en) * 1999-04-29 2008-08-07 Medtronic, Inc. Single and multipolar implantable lead for sacral nerve electrical stimulation

Family Cites Families (165)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3522575A (en) * 1967-06-15 1970-08-04 Amp Inc Hermetically sealed electrical connector
US4076285A (en) * 1975-08-01 1978-02-28 Erika, Inc. Laminar flow connector for conduits
FR2339894B1 (en) 1976-01-30 1979-07-20 Inst Nat Sante Rech Med CORTICAL EVOQUE POTENTIAL ALTERNATION CHRONOMETRY DEVICE
US4187846A (en) * 1978-06-22 1980-02-12 Union Carbide Corporation Sterile connectors
US5127404A (en) * 1990-01-22 1992-07-07 Medtronic, Inc. Telemetry format for implanted medical device
US5228455A (en) * 1991-05-20 1993-07-20 Siemens Pacesetter, Inc. Implant tool for extendable/retractable positive fixation lead
US5255691A (en) 1991-11-13 1993-10-26 Medtronic, Inc. Percutaneous epidural lead introducing system and method
US5284153A (en) 1992-04-14 1994-02-08 Brigham And Women's Hospital Method for locating a nerve and for protecting nerves from injury during surgery
US5330515A (en) 1992-06-17 1994-07-19 Cyberonics, Inc. Treatment of pain by vagal afferent stimulation
US5252090A (en) * 1992-09-30 1993-10-12 Telectronics Pacing Systems, Inc. Self-locking implantable stimulating lead connector
US5417719A (en) 1993-08-25 1995-05-23 Medtronic, Inc. Method of using a spinal cord stimulation lead
US5775331A (en) 1995-06-07 1998-07-07 Uromed Corporation Apparatus and method for locating a nerve
US5662696A (en) * 1995-09-28 1997-09-02 Angeion Corp One piece disposable threshold test can electrode for use with an implantable cardioverter defibrillator system
US5702429A (en) 1996-04-04 1997-12-30 Medtronic, Inc. Neural stimulation techniques with feedback
US5733151A (en) 1996-08-23 1998-03-31 Edsall; David Electrical clamping connection device
US5876408A (en) * 1997-06-12 1999-03-02 Sulzer Intermedics, Inc. Method for enhancing implantation of thin leads
US5906634A (en) * 1997-08-08 1999-05-25 Cardiac Pacemakers, Inc. Implantable device having a quick connect mechanism for leads
US5941906A (en) 1997-10-15 1999-08-24 Medtronic, Inc. Implantable, modular tissue stimulator
US6198969B1 (en) 1998-02-12 2001-03-06 Advanced Bionics Corporation Implantable connector for multi-output neurostimulators
US6402793B1 (en) * 1998-04-03 2002-06-11 Medtronic, Inc. Implantable medical device having flat electrolytic capacitor with cathode/case electrical connections
US6366814B1 (en) 1998-10-26 2002-04-02 Birinder R. Boveja External stimulator for adjunct (add-on) treatment for neurological, neuropsychiatric, and urological disorders
US8244370B2 (en) 2001-04-13 2012-08-14 Greatbatch Ltd. Band stop filter employing a capacitor and an inductor tank circuit to enhance MRI compatibility of active medical devices
US6516227B1 (en) 1999-07-27 2003-02-04 Advanced Bionics Corporation Rechargeable spinal cord stimulator system
US6638237B1 (en) 1999-08-04 2003-10-28 Percardia, Inc. Left ventricular conduits and methods for delivery
US6236892B1 (en) 1999-10-07 2001-05-22 Claudio A. Feler Spinal cord stimulation lead
US6609029B1 (en) 2000-02-04 2003-08-19 Advanced Bionics Corporation Clip lock mechanism for retaining lead
US8611993B2 (en) 2000-03-13 2013-12-17 Arrow International, Inc. Pre-loaded lockable stimulating catheter for delivery of anaesthetic drugs
US6725096B2 (en) 2000-05-05 2004-04-20 Advanced Bionics Corporation Multiple in-line contact connector
US6687538B1 (en) 2000-06-19 2004-02-03 Medtronic, Inc. Trial neuro stimulator with lead diagnostics
US20070087637A1 (en) * 2004-10-15 2007-04-19 Zart Bryan J Connector assembly for an implantable medical device and process for making
DE60017205T2 (en) 2000-07-26 2006-01-12 Advanced Bionics Corp., Sylmar RECHARGEABLE DEVICE FOR STIMULATING THE BACKMARK
FR2812204B1 (en) * 2000-07-31 2003-02-07 Ela Medical Sa ACTIVE IMPLANTABLE MEDICAL DEVICE SUCH AS A CARDIAC STIMULATOR, DEFIBRILLATOR AND / OR CARDIOVERTER COMPRISING A REMOVABLE CONNECTOR HEAD
US6498951B1 (en) * 2000-10-13 2002-12-24 Medtronic, Inc. Implantable medical device employing integral housing for a formable flat battery
US6697677B2 (en) * 2000-12-28 2004-02-24 Medtronic, Inc. System and method for placing a medical electrical lead
US7009313B1 (en) 2001-03-16 2006-03-07 Advanced Bionics Corporation Multi-compliance voltage generator in a multichannel current stimulator
US6901292B2 (en) * 2001-03-19 2005-05-31 Medtronic, Inc. Control of externally induced current in an implantable pulse generator
US6606521B2 (en) * 2001-07-09 2003-08-12 Neuropace, Inc. Implantable medical lead
US20140046407A1 (en) 2001-08-31 2014-02-13 Bio Control Medical (B.C.M.) Ltd. Nerve stimulation techniques
US6993384B2 (en) * 2001-12-04 2006-01-31 Advanced Bionics Corporation Apparatus and method for determining the relative position and orientation of neurostimulation leads
US7096068B2 (en) * 2002-01-17 2006-08-22 Cardiac Pacemakers, Inc. User-attachable or detachable telemetry module for medical devices
US6895276B2 (en) * 2002-02-28 2005-05-17 Medtronic, Inc. In-line lead header for an implantable medical device
US7221981B2 (en) 2002-03-28 2007-05-22 Northstar Neuroscience, Inc. Electrode geometries for efficient neural stimulation
US7697995B2 (en) 2002-04-25 2010-04-13 Medtronic, Inc. Surgical lead paddle
US7860570B2 (en) 2002-06-20 2010-12-28 Boston Scientific Neuromodulation Corporation Implantable microstimulators and methods for unidirectional propagation of action potentials
US20040034392A1 (en) * 2002-08-16 2004-02-19 Cardiac Pacemakers, Inc. Connector module replacement for implantable medical stimulators
US20040106959A1 (en) * 2002-10-10 2004-06-03 Schmidt John A. Implantable Medical Device with Multiple Electrode Lead
ES2340271T3 (en) 2002-12-06 2010-06-01 Boston Scientific Neuromodulation Corporation METHOD FOR DETERMINING STIMULATION PARAMETERS.
US7274963B2 (en) * 2002-12-16 2007-09-25 Cardiac Pacemakers, Inc. Interconnect for implantable medical device header
US7002131B1 (en) * 2003-01-24 2006-02-21 Jds Uniphase Corporation Methods, systems and apparatus for measuring average received optical power
US7343206B2 (en) * 2003-04-25 2008-03-11 Medtronic, Inc. Implantable medical lead and system, and method of use thereof
US7444184B2 (en) 2003-05-11 2008-10-28 Neuro And Cardial Technologies, Llc Method and system for providing therapy for bulimia/eating disorders by providing electrical pulses to vagus nerve(s)
US7303422B2 (en) * 2003-06-04 2007-12-04 Neurostream Technologies Implantable modular, multi-channel connector system for nerve signal sensing and electrical stimulation applications
US7104965B1 (en) 2003-06-06 2006-09-12 The General Hospital Corporation Interactive system and method for peripheral nerve mapping and blocking
KR100547673B1 (en) * 2003-07-16 2006-01-31 엘지전자 주식회사 Microwave oven with air cleaning
US20090312817A1 (en) 2003-11-26 2009-12-17 Wicab, Inc. Systems and methods for altering brain and body functions and for treating conditions and diseases of the same
HRP20030990A2 (en) 2003-11-27 2006-02-28 Branko Breyer Ivo Čikeš System for guidance and control of minimum invasive delivery of therapy with medical agents
US20050203584A1 (en) * 2004-03-10 2005-09-15 Medtronic, Inc. Telemetry antenna for an implantable medical device
US7359751B1 (en) 2004-05-05 2008-04-15 Advanced Neuromodulation Systems, Inc. Clinician programmer for use with trial stimulator
US7865250B2 (en) * 2004-06-10 2011-01-04 Medtronic Urinary Solutions, Inc. Methods for electrical stimulation of nerves in adipose tissue regions
US8165692B2 (en) * 2004-06-10 2012-04-24 Medtronic Urinary Solutions, Inc. Implantable pulse generator power management
US8195304B2 (en) 2004-06-10 2012-06-05 Medtronic Urinary Solutions, Inc. Implantable systems and methods for acquisition and processing of electrical signals
IL162854A (en) * 2004-07-04 2011-08-31 Igal Sharon Syringe assembly
WO2006029007A2 (en) * 2004-09-02 2006-03-16 E-Soc Device for brain stimulation using rf energy harvesting
US20100331883A1 (en) 2004-10-15 2010-12-30 Schmitz Gregory P Access and tissue modification systems and methods
US9026228B2 (en) 2004-10-21 2015-05-05 Medtronic, Inc. Transverse tripole neurostimulation lead, system and method
US10537741B2 (en) 2004-12-03 2020-01-21 Boston Scientific Neuromodulation Corporation System and method for choosing electrodes in an implanted stimulator device
US20060167522A1 (en) 2005-01-25 2006-07-27 Malinowski Zdzislaw B Connector for use in an implantable stimulator device
US7144274B2 (en) * 2005-03-07 2006-12-05 Sri Hermetics, Inc. Hermetically sealed, weldable connectors
US7751884B2 (en) 2005-04-28 2010-07-06 Cardiac Pacemakers, Inc. Flexible neural stimulation engine
EP1904154B1 (en) * 2005-06-09 2011-01-26 Medtronic, Inc. Implantable medical lead
US8606362B2 (en) 2005-07-08 2013-12-10 Boston Scientific Neuromodulation Corporation Current output architecture for an implantable stimulator device
US7697985B2 (en) 2005-07-26 2010-04-13 Medtronic, Inc. System and method for providing alternative pacing modality selection
US7680540B2 (en) 2005-07-29 2010-03-16 Medtronic, Inc. Multi-application trial stimulator
US7450992B1 (en) 2005-08-18 2008-11-11 Advanced Neuromodulation Systems, Inc. Method for controlling or regulating therapeutic nerve stimulation using electrical feedback
AU2006280946B2 (en) * 2005-08-19 2013-05-02 Neuronetrix Solutions, Llc Controller for neuromuscular testing
US7640059B2 (en) 2005-09-08 2009-12-29 Medtronic, Inc. External presentation of electrical stimulation parameters
US7590451B2 (en) 2005-10-31 2009-09-15 Medtronic, Inc. Axial lead connector for implantable medical devices
US7872884B2 (en) * 2005-11-03 2011-01-18 Boston Scientific Neuromodulation Corporation Cascaded step-up converter and charge pump for efficient compliance voltage generation in an implantable stimulator device
US10441780B2 (en) 2005-11-10 2019-10-15 Electrocore, Inc. Systems and methods for vagal nerve stimulation
US7444181B2 (en) 2005-12-14 2008-10-28 Boston Scientific Neuromodulation Corporation Techniques for sensing and adjusting a compliance voltage in an implantable stimulator device
WO2007070584A2 (en) 2005-12-16 2007-06-21 Access Scientific Needle constructed with a transparent or translucent material
US8700178B2 (en) 2005-12-27 2014-04-15 Boston Scientific Neuromodulation Corporation Stimulator leads and methods for lead fabrication
US9339641B2 (en) 2006-01-17 2016-05-17 Emkinetics, Inc. Method and apparatus for transdermal stimulation over the palmar and plantar surfaces
US8285379B2 (en) * 2006-01-30 2012-10-09 Medtronic, Inc. Electrical interconnection structures and method
US7526339B2 (en) 2006-03-27 2009-04-28 Medtronic, Inc. IPG connector headers for implantable medical devices
US8712539B2 (en) * 2006-04-12 2014-04-29 Medtronic, Inc. Rule-based stimulation program search
US7949408B2 (en) 2006-04-28 2011-05-24 Medtronic, Inc. System and method for electrically probing and providing medical electrical stimulation
US7738966B2 (en) 2006-08-21 2010-06-15 Medtronic, Inc. Features for routing conductors in medical electrical lead electrode assemblies
WO2008025159A1 (en) * 2006-08-28 2008-03-06 Victhom Human Bionics Inc. High density implantable connector
US7445528B1 (en) * 2006-09-29 2008-11-04 Boston Scientific Neuromodulation Corporation Connector assemblies
EP2069011B1 (en) 2006-10-06 2013-11-20 Neurostream Technologies General Partnership Implantable pulse generator
US8417343B2 (en) 2006-10-13 2013-04-09 Apnex Medical, Inc. Obstructive sleep apnea treatment devices, systems and methods
US9352161B2 (en) 2006-10-26 2016-05-31 Boston Scientific Neuromodulation Corporation Method of maintaining intensity output while adjusting pulse width or amplitude
US7347746B1 (en) * 2006-10-27 2008-03-25 Boston Scientific Neuromodulation Corporation Receptacle connector assembly
US8688238B2 (en) * 2006-10-31 2014-04-01 Medtronic, Inc. Implantable medical elongated member including fixation elements along an interior surface
US20080132979A1 (en) * 2006-11-30 2008-06-05 Medtronic, Inc. Method of implanting a medical lead
US20080183225A1 (en) * 2007-01-31 2008-07-31 Adamski Thomas H Orientation-independent implantable electrode arrays
CA2680639C (en) 2007-03-19 2017-03-07 University Of Virginia Patent Foundation Access needle pressure sensor device and method of use
US8954162B2 (en) * 2007-04-25 2015-02-10 Medtronic, Inc. Medical device implantation
US8206175B2 (en) 2007-05-03 2012-06-26 Deringer-Ney, Inc. Visual indicator of proper interconnection for an implanted medical device
US7976469B2 (en) 2007-06-04 2011-07-12 Medtronic, Inc. Percutaneous needle guide
US7794256B1 (en) * 2007-08-09 2010-09-14 Jerzy Roman Sochor Implantable connector with contact-containing feedthrough pins
US7978062B2 (en) 2007-08-31 2011-07-12 Cardiac Pacemakers, Inc. Medical data transport over wireless life critical network
US8380314B2 (en) 2007-09-26 2013-02-19 Medtronic, Inc. Patient directed therapy control
RU72856U1 (en) 2007-10-19 2008-05-10 ГУ Московская городская онкологическая больница N 62 Департамента здравоохранения гор. Москвы DEVICE FOR EMERGENCY DRAINING OF THE CUP AND PULPOUS SYSTEM
US9044542B2 (en) 2007-12-21 2015-06-02 Carticept Medical, Inc. Imaging-guided anesthesia injection systems and methods
US7798864B2 (en) 2008-03-12 2010-09-21 Boston Scientific Neuromodulation Corporation Low-profile connector for a neurostimulation lead
WO2009117599A2 (en) * 2008-03-20 2009-09-24 Greatbatch Ltd. Shielded three-terminal flat-through emi/energy dissipating filter
US8473056B2 (en) * 2008-04-25 2013-06-25 Medtronic, Inc. Assembly method for implantable medical device
US20090275997A1 (en) * 2008-05-01 2009-11-05 Michael Allen Faltys Vagus nerve stimulation electrodes and methods of use
US7806862B2 (en) 2008-05-02 2010-10-05 Molnar James M Regional anesthesia system and cart
US7736191B1 (en) * 2008-05-27 2010-06-15 Jerzy Roman Sochor Implantable connector with protected contacts
US9776008B2 (en) * 2008-07-11 2017-10-03 Medtronic, Inc. Posture state responsive therapy delivery using dwell times
CA2732732C (en) 2008-08-01 2016-04-12 Jonathan L. Sakai Portable assemblies, systems, and methods for providing functional or therapeutic neurostimulation
WO2010034343A1 (en) * 2008-09-24 2010-04-01 Neurotech Hyperboloid electrical connector assembly
US8788064B2 (en) 2008-11-12 2014-07-22 Ecole Polytechnique Federale De Lausanne Microfabricated neurostimulation device
US8504160B2 (en) 2008-11-14 2013-08-06 Boston Scientific Neuromodulation Corporation System and method for modulating action potential propagation during spinal cord stimulation
EP2401029A1 (en) 2009-01-30 2012-01-04 Medtronic, Inc. Closed-loop neurostimulation to treat pulmonary edema
US8335569B2 (en) 2009-02-10 2012-12-18 Boston Scientific Neuromodulation Corporation External device for communicating with an implantable medical device having data telemetry and charging integrated in a single housing
US8690776B2 (en) 2009-02-17 2014-04-08 Inneroptic Technology, Inc. Systems, methods, apparatuses, and computer-readable media for image guided surgery
US8600507B2 (en) 2009-07-21 2013-12-03 Boston Scientific Neuromodulation Corporation Multi-port modular connector for implantable electrical stimulation systems and methods of making and using
WO2011031455A2 (en) 2009-08-25 2011-03-17 Polyplus Battery Company Implantable electrode assembly, implantable electrochemical power cells and implantable medical device assemblies
US8929998B2 (en) * 2009-09-30 2015-01-06 Mayo Foundation For Medical Education And Research Percutaneous placement of electrodes
WO2011053196A1 (en) 2009-10-27 2011-05-05 St. Jude Medical Ab Implantable medical device power saving communication
US8632465B1 (en) 2009-11-03 2014-01-21 Vivaquant Llc Physiological signal denoising
US9113950B2 (en) 2009-11-04 2015-08-25 Regenerative Sciences, Llc Therapeutic delivery device
US8457756B2 (en) 2009-11-11 2013-06-04 Boston Scientific Neuromodulation Corporation Using the case of an implantable medical device to broaden communication bandwidth
US8873220B2 (en) * 2009-12-18 2014-10-28 Cardiac Pacemakers, Inc. Systems and methods to connect sintered aluminum electrodes of an energy storage device
EP3636314B1 (en) 2009-12-23 2021-09-08 Setpoint Medical Corporation Neural stimulation devices and systems for treatment of chronic inflammation
BR112012016311A2 (en) 2009-12-30 2017-03-28 Ams Res Corp multifunctional tool usable in a procedure to install a pelvic implant
US9357949B2 (en) * 2010-01-08 2016-06-07 Medtronic, Inc. User interface that displays medical therapy and posture data
CA2790326A1 (en) 2010-02-17 2011-08-25 University Of Virginia Patent Foundation Access system for femoral vasculature catheterization and related method
EP2539016B1 (en) * 2010-02-22 2017-11-01 Richard B. North Percutaneous electrode system
US8100019B2 (en) 2010-04-07 2012-01-24 Mkt Engineering, Llc Cartridge fluid transducer
EP2600923B1 (en) 2010-06-10 2018-08-08 Anthony J. Colantonio Apparatus and method for safely inserting an introducer needle into epidural space
WO2011163368A1 (en) 2010-06-24 2011-12-29 Cdw Investments, Llc Hyperechogenic needles
US9044616B2 (en) 2010-07-01 2015-06-02 Boston Scientific Neuromodulation Corporation Charging system for an implantable medical device employing magnetic and electric fields
EP2593177B1 (en) * 2010-07-16 2021-10-20 Boston Scientific Neuromodulation Corporation Systems and methods for radial steering of electrode arrays
WO2012027791A1 (en) * 2010-08-31 2012-03-08 National Ict Australia Ltd Distributed implant systems
CA2813061C (en) 2010-10-13 2016-05-10 Boston Scientific Neuromodulation Corporation Architectures for an implantable medical device system having daisy-chained electrode-driver integrated circuits
WO2012061608A2 (en) 2010-11-03 2012-05-10 The Cleveland Clinic Foundation Apparatus for energy efficient stimulation
US9259574B2 (en) 2010-11-17 2016-02-16 Boston Scientific Neuromodulation Corporation External trial stimulator useable in an implantable neurostimulator system
CA2822886A1 (en) 2010-12-23 2012-06-28 Boston Scientific Neuromodulation Corporation Neurostimulation system for estimating desired stimulation amplitude for electrode configuration
US20140018732A1 (en) * 2011-01-10 2014-01-16 Spotlight Technology Partners Llc Apparatus and Methods for Accessing and Treating a Body Cavity, Lumen, or Ostium
US8634927B2 (en) 2011-01-28 2014-01-21 Medtronic, Inc. Medical device recharge systems using a controller in wireless communication with a separate recharge device
EP4218917A1 (en) 2011-02-24 2023-08-02 Boston Scientific Neuromodulation Corporation Implantable neurostimulator with a circuit board and a connector
CA2835448C (en) * 2011-05-13 2020-08-18 Saluda Medical Pty Limited Method and apparatus for controlling a neural stimulus - e
EP3263038B1 (en) 2011-05-18 2023-08-30 Solo-Dex, Inc. Continuous anesthesia nerve conduction apparatus
US20130072941A1 (en) 2011-09-16 2013-03-21 Francisca Tan-Malecki Cement Injector and Cement Injector Connectors, and Bone Cement Injector Assembly
US9950179B2 (en) 2011-10-28 2018-04-24 Medtronic, Inc. Medical devices for trial stimulation
US20130123866A1 (en) 2011-11-10 2013-05-16 Boston Scientific Neuromodulation Corporation Neurostimulation system with lead fastener and methods of making and using
US8600505B2 (en) 2011-12-07 2013-12-03 Cyberonics, Inc. Implantable device for facilitating control of electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction
US20140058189A1 (en) 2012-02-20 2014-02-27 William F. Stubbeman Systems and methods using brain stimulation for treating disorders
EP2825253A1 (en) 2012-03-16 2015-01-21 Boston Scientific Neuromodulation Corporation Field augmented current steering using voltage sources
EP2828937A4 (en) * 2012-03-21 2015-11-11 Bal Seal Engineering Inc Connectors with electrical or signal carrying capabilities and related methods
US9174051B2 (en) 2012-04-29 2015-11-03 Boston Scientific Neuromodulation Corporation Real time compliance voltage generation for an implantable stimulator
US9314632B2 (en) 2012-05-17 2016-04-19 Boston Scientific Neuromodulation Corporation Pulse-by-pulse compliance voltage generation for an implantable stimulator
US8843215B2 (en) * 2012-06-13 2014-09-23 Biotronik Se & Co. Kg Connecting device
WO2013192206A1 (en) 2012-06-18 2013-12-27 The Cleveland Clinic Foundation Dynamic compliance voltage for energy efficient stimulation
WO2014036184A2 (en) 2012-08-29 2014-03-06 University Of Southern California Monitoring and controlling charge rate and level of battery in inductively-charged pulse generating device
US8761897B2 (en) 2012-08-31 2014-06-24 Greatbatch Ltd. Method and system of graphical representation of lead connector block and implantable pulse generators on a clinician programmer
US9427565B2 (en) * 2012-11-07 2016-08-30 The Florida International University Board Of Trustees Modular multi-channel inline connector system
US9533148B2 (en) * 2013-02-22 2017-01-03 Boston Scientific Neuromodulation Corporation Neurostimulation system and method for automatically adjusting stimulation and reducing energy requirements using evoked action potential
US9002447B2 (en) * 2013-03-14 2015-04-07 Medtronic, Inc. Implantable medical device having power supply for generating a regulated power supply
US9539422B2 (en) * 2013-07-02 2017-01-10 Greatbatch Ltd. Neurostimulator interconnection apparatus, system, and method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6119044A (en) * 1997-06-02 2000-09-12 Advanced Bionics Corporation Cochlear electrode array with positioning stylet
US20080188917A1 (en) * 1999-04-29 2008-08-07 Medtronic, Inc. Single and multipolar implantable lead for sacral nerve electrical stimulation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210265922A1 (en) * 2020-02-20 2021-08-26 Toyota Jidosha Kabushiki Kaisha Actuator and actuator manufacturing method

Also Published As

Publication number Publication date
US9636497B2 (en) 2017-05-02
US9295832B2 (en) 2016-03-29
US20170333701A1 (en) 2017-11-23
US20150012068A1 (en) 2015-01-08
US20150012067A1 (en) 2015-01-08
US20150018910A1 (en) 2015-01-15
US20150012064A1 (en) 2015-01-08
US20170246451A1 (en) 2017-08-31
US9539422B2 (en) 2017-01-10
US11135424B2 (en) 2021-10-05
US9526897B2 (en) 2016-12-27
US20150012061A1 (en) 2015-01-08
US20160287878A1 (en) 2016-10-06
US9744347B2 (en) 2017-08-29
US20170232260A1 (en) 2017-08-17
US9764128B2 (en) 2017-09-19
US9415211B2 (en) 2016-08-16
US20150018912A1 (en) 2015-01-15
US9731116B2 (en) 2017-08-15
US9750930B2 (en) 2017-09-05
US10384054B2 (en) 2019-08-20
US10376688B2 (en) 2019-08-13
US9227052B2 (en) 2016-01-05
US20150012062A1 (en) 2015-01-08
US20160144188A1 (en) 2016-05-26
US20150011871A1 (en) 2015-01-08
US10463852B2 (en) 2019-11-05
US9248279B2 (en) 2016-02-02
US10456574B2 (en) 2019-10-29
US20150012063A1 (en) 2015-01-08
US20170065813A1 (en) 2017-03-09
US20150012071A1 (en) 2015-01-08

Similar Documents

Publication Publication Date Title
US20150018911A1 (en) Apparatus, system, and method for minimized energy in peripheral field stimulation
JP4879754B2 (en) Method for carrying electrical current to body tissue via implanted non-active conductor
JP5108787B2 (en) A method for routing current to body tissue through embedded passive conductors
US8738153B2 (en) Implantable lead with braided conductors
US8509920B2 (en) Electrode arrangements for medical lead
AU2010263218B2 (en) Medical device lead including a unifilar coil with improved torque transmission capacity and reduced MRI heating
US10478613B2 (en) Temporary implantable medical electrical stimulation lead
US20090012590A1 (en) Neural Conductor
CN113747936A (en) Electrode for electrical stimulation to treat cancer
AU2014290582B2 (en) Multi-electrode lead with backing for mecho/baroreceptor stimulation
WO2020051484A1 (en) Peripheral nerve modulator and methods relating to peripheral nerve modulation
US11904161B2 (en) Deployable electrode array lead assembly for implantable electrical stimulation
Koppaka et al. Directed stimulation with interfascicular interfaces for peripheral nerve stimulation
US8929993B2 (en) Electrode arrangements for suborbital foramen medical lead
Gan The stimulus router system: A novel neural prosthesis

Legal Events

Date Code Title Description
AS Assignment

Owner name: GREATBATCH LTD., NEW YORK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BRADLEY, KERRY;REEL/FRAME:033302/0550

Effective date: 20140710

AS Assignment

Owner name: MANUFACTURERS AND TRADERS TRUST COMPANY, NEW YORK

Free format text: SECURITY INTEREST;ASSIGNORS:GREATBATCH, INC.;GREATBATCH LTD.;ELECTROCHEM SOLUTIONS, INC.;AND OTHERS;REEL/FRAME:036980/0482

Effective date: 20151027

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: MICRO POWER ELECTRONICS, INC., NEW YORK

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:060938/0069

Effective date: 20210903

Owner name: PRECIMED INC., NEW YORK

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:060938/0069

Effective date: 20210903

Owner name: GREATBATCH-GLOBE TOOL, INC., NEW YORK

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:060938/0069

Effective date: 20210903

Owner name: NEURONEXUS TECHNOLOGIES, INC., NEW YORK

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:060938/0069

Effective date: 20210903

Owner name: ELECTROCHEM SOLUTIONS, INC., NEW YORK

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:060938/0069

Effective date: 20210903

Owner name: GREATBATCH LTD., NEW YORK

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:060938/0069

Effective date: 20210903

Owner name: GREATBATCH, INC., NEW YORK

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:060938/0069

Effective date: 20210903

AS Assignment

Owner name: MICRO POWER ELECTRONICS, INC., NEW YORK

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:061659/0858

Effective date: 20210903

Owner name: PRECIMED INC., NEW YORK

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:061659/0858

Effective date: 20210903

Owner name: GREATBATCH-GLOBE TOOL, INC., NEW YORK

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:061659/0858

Effective date: 20210903

Owner name: NEURONEXUS TECHNOLOGIES, INC., NEW YORK

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:061659/0858

Effective date: 20210903

Owner name: ELECTROCHEM SOLUTIONS, INC., NEW YORK

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:061659/0858

Effective date: 20210903

Owner name: GREATBATCH LTD., NEW YORK

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:061659/0858

Effective date: 20210903

Owner name: GREATBATCH, INC., NEW YORK

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT);REEL/FRAME:061659/0858

Effective date: 20210903